,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,485,1,8,,26719891,60795,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
1,631,1,4,,26719891,60795,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
2,631,1,4,,26719891,60795,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
3,731,1,5,,26719891,60795,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
4,731,1,5,,26719891,60795,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
5,781,1,1,,26719891,60795,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
6,782,1,2,,26719891,60795,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
7,782,1,2,,26719891,60795,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
8,880,2,1,,26719891,60795,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
9,880,2,1,,26719891,60795,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
10,880,2,1,,29215485,60795,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
11,880,2,1,,29215485,60795,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
12,881,2,2,,29215485,60795,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
13,894,2,1,,29215485,60795,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
14,950,1,1,,26719891,60795,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
15,951,1,1,,26719891,60795,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
16,952,1,1,,26719891,60795,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
17,1001,2,2,,26719891,60795,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
18,1006,1,6,,26719891,60795,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
19,1007,1,1,,26719891,60795,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
20,1008,1,2,,26719891,60795,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
21,1009,1,2,,26719891,60795,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
22,1012,1,4,,26719891,60795,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
23,1016,1,4,,26719891,60795,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
24,1018,2,5,,26719891,60795,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
25,1019,1,4,,26719891,60795,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
26,1020,1,5,,26719891,60795,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
27,1021,1,1,,26719891,60795,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
28,1022,1,1,,26719891,60795,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
29,1027,1,3,,26719891,60795,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
30,1030,2,1,,29215485,60795,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
31,1032,1,2,,26719891,60795,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
32,1032,1,2,,26719891,60795,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
33,1040,1,2,,26719891,60795,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
34,1048,1,1,,26719891,60795,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
35,1048,1,1,,26719891,60795,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
36,1049,1,1,,26719891,60795,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
37,1049,1,1,,26719891,60795,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
38,1051,1,1,,26719891,60795,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
39,1051,1,1,,26719891,60795,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
40,1066,1,2,,26719891,60795,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
41,1085,1,1,,26719891,60795,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
42,1135,1,3,,26719891,60795,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
43,1136,1,3,,26719891,60795,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
44,1203,1,3,,26719891,60795,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
45,1209,2,2,,26719891,60795,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
46,1214,1,4,,26719891,60795,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
47,1216,1,5,,26719891,60795,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
48,1217,1,4,,26719891,60795,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
49,1220,2,2,,26719891,60795,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
50,1222,1,6,,26719891,60795,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
51,1229,1,3,,26719891,60795,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
52,1236,1,1,,26719891,60795,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
53,1251,1,1,,26719891,60795,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
54,1274,1,2,,26719891,60795,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
55,1304,1,2,,26719891,60795,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
56,1321,1,2,,26719891,60795,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
57,1325,1,2,,26719891,60795,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
58,1359,1,4,,26719891,60795,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
59,1362,1,2,,26719891,60795,Active,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
60,1376,1,2,,49681659,60795,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
61,1379,1,2,,29215485,60795,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
62,1385,2,2,,49681659,60795,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
63,1415,1,2,,26719891,60795,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
64,1415,1,2,,26719891,60795,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
65,1416,1,2,,26719891,60795,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
66,1422,1,1,,49681659,60795,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
67,1423,1,2,,26719891,60795,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
68,1423,1,2,,26719891,60795,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
69,1424,1,1,,26719891,60795,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
70,1434,2,3,,26719891,60795,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
71,1434,2,3,,26719891,60795,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
72,1439,1,1,,26719891,60795,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
73,1439,1,1,,26719891,60795,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
74,1440,1,1,,26719891,60795,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
75,1440,1,1,,26719891,60795,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
76,1441,1,1,,26719891,60795,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
77,1441,1,1,,26719891,60795,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
78,1443,1,3,,26719891,60795,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
79,1445,1,1,,26719891,60795,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
80,1446,1,3,,26719891,60795,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
81,1448,1,3,,26719891,60795,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
82,1452,1,1,,29215485,60795,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
83,1454,1,1,,26719891,60795,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
84,1456,1,1,,26719891,60795,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
85,1457,1,1,,29215485,60795,Inactive,44888968.0,83523.0,7.9433,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
86,1460,1,3,,26719891,60795,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
87,1460,1,3,,29215485,60795,Inconclusive,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
88,1461,1,2,,26719891,60795,Inconclusive,46395496.0,387129.0,12.5893,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
89,1463,1,1,,26719891,60795,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
90,1463,1,1,,29215485,60795,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
91,1465,1,1,,49681659,60795,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
92,1466,1,2,,26719891,60795,Inconclusive,119393891.0,2548.0,1.7783,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
93,1467,1,3,,26719891,60795,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
94,1467,1,3,,29215485,60795,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
95,1468,1,1,,26719891,60795,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
96,1468,1,1,,29215485,60795,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
97,1469,1,1,,26719891,60795,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
98,1469,1,1,,29215485,60795,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
99,1471,2,1,,29215485,60795,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
100,1476,2,1,,29215485,60795,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
101,1477,1,1,,26719891,60795,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
102,1477,1,1,,29215485,60795,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
103,1478,2,1,,29215485,60795,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
104,1479,1,2,,26719891,60795,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
105,1479,1,2,,29215485,60795,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
106,1481,1,2,,26719891,60795,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
107,1486,1,3,,26719891,60795,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
108,1487,1,1,,29215485,60795,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
109,1490,2,1,,26719891,60795,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
110,1490,2,1,,29215485,60795,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
111,1496,1,4,,26719891,60795,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
112,1496,1,4,,26719891,60795,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
113,1509,1,2,,26719891,60795,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
114,1510,1,3,,26719891,60795,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
115,1511,1,3,,49666418,60795,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
116,1515,1,2,,26719891,60795,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
117,1527,1,3,,26719891,60795,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
118,1529,1,1,,26719891,60795,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
119,1529,1,1,,49681659,60795,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
120,1530,1,1,,26719891,60795,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
121,1530,1,1,,49681659,60795,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
122,1531,1,1,,26719891,60795,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
123,1531,1,1,,49681659,60795,Active,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
124,1532,1,1,,49681659,60795,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
125,1533,1,1,,26719891,60795,Inactive,15610402.0,888704.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
126,1533,1,1,,26719891,60795,Inactive,15610601.0,887352.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
127,1554,1,1,,49666418,60795,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
128,1556,1,4,,26719891,60795,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
129,1565,2,2,,26719891,60795,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
130,1566,2,3,,26719891,60795,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
131,1578,3,2,,26719891,60795,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
132,1619,1,2,,26719891,60795,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
133,1621,1,2,,49681659,60795,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
134,1625,2,2,,26719891,60795,Inactive,,,,EC50,HCS for Compounds that Up-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
135,1626,1,2,,26719891,60795,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
136,1626,1,2,,49681659,60795,Inconclusive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
137,1628,2,2,,26719891,60795,Inactive,,,,IC50,HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
138,1631,3,1,,26719891,60795,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
139,1634,3,1,,26719891,60795,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
140,1654,2,2,,26719891,60795,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
141,1656,2,2,,26719891,60795,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
142,1662,1,2,,49666418,60795,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
143,1663,1,2,,49666418,60795,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
144,1665,2,2,,26719891,60795,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
145,1672,1,3,,49666418,60795,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
146,1688,1,1,,29215485,60795,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
147,1700,1,2,,26719891,60795,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
148,1706,1,2,,26719891,60795,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
149,1721,1,2,,26719891,60795,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
150,1722,1,2,,26719891,60795,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
151,1766,1,1,,26719891,60795,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
152,1766,1,1,,26719891,60795,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
153,1766,1,1,,29215485,60795,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
154,1766,1,1,,29215485,60795,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
155,1768,1,1,,26719891,60795,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
156,1768,1,1,,26719891,60795,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
157,1768,1,1,,29215485,60795,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
158,1768,1,1,,29215485,60795,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
159,1775,1,2,,26719891,60795,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
160,1776,1,2,,26719891,60795,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
161,1777,3,2,,26719891,60795,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
162,1778,3,3,,26719891,60795,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
163,1779,2,2,,26719891,60795,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
164,1789,1,2,,26719891,60795,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
165,1800,1,2,,26719891,60795,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
166,1813,1,2,,49666418,60795,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
167,1814,1,2,,49666418,60795,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
168,1817,2,2,,26719891,60795,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
169,1822,1,3,,26719891,60795,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
170,1825,1,1,,26719891,60795,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
171,1832,2,1,,49666418,60795,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
172,1845,1,2,,26719891,60795,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
173,1850,2,1,,49666418,60795,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
174,1861,2,1,,26719891,60795,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
175,1863,2,1,,26719891,60795,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
176,1863,2,1,,49666418,60795,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
177,1865,1,1,,26719891,60795,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
178,1865,1,1,,29215485,60795,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
179,1868,1,4,,26719891,60795,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
180,1875,2,1,,49666418,60795,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
181,1885,2,1,,49666418,60795,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
182,1892,1,1,,49681659,60795,Active,22035600.0,5871.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
183,1893,1,1,,49681659,60795,Inactive,22035600.0,5871.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
184,1894,1,1,,49681659,60795,Active,42794767.0,4215.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
185,1899,1,3,,49666418,60795,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
186,1903,2,3,,26719891,60795,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
187,1903,2,3,,49666418,60795,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
188,1906,1,3,,49666418,60795,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
189,1910,1,2,,49666418,60795,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
190,1947,1,2,,49666418,60795,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
191,1948,1,1,,29215485,60795,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
192,1950,1,3,,49666418,60795,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
193,1956,1,1,,49681659,60795,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
194,1961,2,2,,26719891,60795,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
195,1962,1,2,,49666418,60795,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
196,1974,1,2,,49666418,60795,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
197,1979,1,1,,49666418,60795,Active,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
198,1984,1,3,,26719891,60795,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
199,1986,1,2,,26719891,60795,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
200,1987,1,2,,49666418,60795,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
201,1996,2,2,,49666418,60795,Inactive,,,,,Aqueous Solubility from MLSMR Stock Solutions,Other,,
202,2006,3,2,,26719891,60795,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
203,2006,3,2,,26719891,60795,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
204,2006,3,2,,26719891,60795,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
205,2012,3,2,,26719891,60795,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
206,2013,2,2,,26719891,60795,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
207,2014,3,2,,26719891,60795,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
208,2016,1,3,,49666418,60795,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
209,2023,1,3,,49666418,60795,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
210,2025,1,3,,49666418,60795,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
211,2029,1,3,,49666418,60795,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
212,2052,2,1,,49666418,60795,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
213,2057,1,2,,49666418,60795,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
214,2058,3,2,,26719891,60795,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
215,2062,1,2,,85209988,60795,Active,,,,,Ligands of bioamine (Class A) GPCRs,Other,,
216,2066,1,4,,49666418,60795,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
217,2071,2,2,,26719891,60795,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
218,2073,2,3,,26719891,60795,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
219,2073,2,3,,26719891,60795,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
220,2094,1,2,,49666418,60795,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
221,2094,1,2,,49666418,60795,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
222,2094,1,2,,49666418,60795,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
223,2097,1,2,,49666418,60795,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
224,2098,1,1,,49666418,60795,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
225,2099,1,1,,49666418,60795,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
226,2100,1,1,,26719891,60795,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
227,2101,1,1,,26719891,60795,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
228,2101,1,1,,29215485,60795,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
229,2107,1,1,,26719891,60795,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
230,2107,1,1,,29215485,60795,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
231,2112,1,1,,26719891,60795,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
232,2112,1,1,,29215485,60795,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
233,2129,1,2,,49666418,60795,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
234,2130,1,3,,49666418,60795,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
235,2147,1,1,,26719891,60795,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
236,2156,2,2,,49666418,60795,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
237,2174,1,3,,49666418,60795,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
238,2177,1,3,,49666418,60795,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
239,2216,1,3,,49666418,60795,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
240,2221,1,2,,49666418,60795,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
241,2227,1,2,,49666418,60795,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
242,2234,1,2,,49666418,60795,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
243,2235,1,2,,49666418,60795,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
244,2237,1,2,,49666418,60795,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
245,2239,1,2,,49666418,60795,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
246,2242,1,1,,26719891,60795,Inconclusive,119393891.0,2548.0,1.7783,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
247,2247,1,2,,49666418,60795,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
248,2280,2,3,,49666418,60795,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
249,2288,1,1,,26719891,60795,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
250,2289,1,1,,26719891,60795,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
251,2300,1,3,,49666418,60795,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
252,2314,1,2,,26719891,60795,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
253,2314,1,2,,26719891,60795,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
254,2314,1,2,,29215485,60795,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
255,2314,1,2,,29215485,60795,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
256,2315,1,2,,26719891,60795,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
257,2315,1,2,,26719891,60795,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
258,2315,1,2,,29215485,60795,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
259,2315,1,2,,29215485,60795,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
260,2380,1,2,,49666418,60795,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
261,2391,1,1,,49666418,60795,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
262,2435,1,2,,49666418,60795,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
263,2445,1,2,,49666418,60795,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
264,2451,1,2,,26719891,60795,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
265,2451,1,2,,29215485,60795,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
266,2462,1,1,,49666418,60795,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
267,2462,1,1,,49666418,60795,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
268,2472,1,2,,26719891,60795,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
269,2472,1,2,,29215485,60795,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
270,2517,2,1,,26719891,60795,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
271,2517,2,1,,144205281,60795,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
272,2520,1,4,,49666418,60795,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
273,2521,1,3,,49666418,60795,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
274,2524,1,2,,49666418,60795,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
275,2528,1,2,,26719891,60795,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
276,2528,1,2,,29215485,60795,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
277,2540,1,2,,49666418,60795,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
278,2544,1,2,,49666418,60795,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
279,2546,1,1,,26719891,60795,Inconclusive,188536040.0,19885.0,0.7079,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
280,2546,1,1,,29215485,60795,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
281,2549,1,1,,26719891,60795,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
282,2549,1,1,,29215485,60795,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
283,2550,1,3,,49666418,60795,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
284,2551,1,1,,26719891,60795,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
285,2551,1,1,,29215485,60795,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
286,2553,1,2,,49666418,60795,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
287,2557,1,3,,49666418,60795,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
288,2563,1,1,,49666418,60795,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
289,2599,1,2,,49666418,60795,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
290,2606,1,2,,49666418,60795,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
291,2629,1,1,,49666418,60795,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
292,2642,1,2,,49666418,60795,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
293,2648,1,2,,49666418,60795,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
294,2650,2,1,,49666418,60795,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
295,2661,1,1,,49666418,60795,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
296,2662,2,1,,26719891,60795,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
297,2662,2,1,,29215485,60795,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
298,2675,1,1,,26719891,60795,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
299,2676,1,2,,26719891,60795,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
300,2685,1,1,,26719891,60795,Inconclusive,,,20.5962,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
301,2690,1,2,,49666418,60795,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
302,2716,1,1,,49666418,60795,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
303,2717,1,2,,49666418,60795,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
304,2718,1,1,,49666418,60795,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
305,2732,1,1,,26719891,60795,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
306,2751,2,2,,49666418,60795,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
307,2796,1,4,,49666418,60795,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
308,2797,1,2,,49666418,60795,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
309,2805,2,2,,49666418,60795,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
310,2806,2,2,,49666418,60795,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
311,2825,1,2,,49666418,60795,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
312,6677,8,5,,103307946,60795,Active,8488960.0,3363.0,0.013999999999999999,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,Confirmatory,12825922.0,
313,113543,7,2,,103307946,60795,Unspecified,,,,,Induction of catalepsy in mice,Other,9513593.0,
314,113713,7,2,,103307946,60795,Unspecified,,,,,Inhibition of the APO-induced stereotyped behavior in mice,Other,9513593.0,
315,113715,7,2,,103307946,60795,Unspecified,,,,,Inhibition of the GBL-induced increase in DOPA accumulation in mice(DA auto receptor agonist activity),Other,9513593.0,
316,113717,7,2,,103307946,60795,Unspecified,,,,,Inhibition of the GBL-induced increase in DOPA synthesis in mice.,Other,9513593.0,
317,113720,7,8,,103307946,60795,Unspecified,3023234.0,11548.0,,,Inhibition of the lethal effects of noradrenaline in mice (alpha-1 induced adrenoceptor antagonist activity),Other,9513593.0,
318,113720,7,8,,103307946,60795,Unspecified,3121722.0,11550.0,,,Inhibition of the lethal effects of noradrenaline in mice (alpha-1 induced adrenoceptor antagonist activity),Other,9513593.0,
319,113720,7,8,,103307946,60795,Unspecified,341940608.0,11549.0,,,Inhibition of the lethal effects of noradrenaline in mice (alpha-1 induced adrenoceptor antagonist activity),Other,9513593.0,
320,114076,7,3,,103307946,60795,Unspecified,,,,,post-synaptic dopamine autoreceptor antagonist activity evaluated by inhibition of the apomorphine-induced stereotyped behavior in mice.,Other,9513593.0,
321,114205,7,2,,103307946,60795,Unspecified,,,,,post-synaptic DA receptor antagonist activity was evaluated by inhibition of the apomorphine-induced stereotyped behavior in mice. inactive at single given dose,Other,9513593.0,
322,234393,4,3,,103307946,60795,Unspecified,,,,,ratio between ED50 values of DA receptor antagonist activity and catalepsy.,Other,9513593.0,
323,277668,3,10,,103307946,60795,Unspecified,118206.0,1813.0,,,Selectivity for dopamine D3 over dopamine D2,Other,17266201.0,
324,277668,3,10,,103307946,60795,Unspecified,1169206.0,1814.0,,,Selectivity for dopamine D3 over dopamine D2,Other,17266201.0,
325,277669,3,11,,103307946,60795,Unspecified,1169206.0,1814.0,,,Selectivity for dopamine D3 over dopamine D4,Other,17266201.0,
326,277669,3,11,,103307946,60795,Unspecified,1345939.0,1815.0,,,Selectivity for dopamine D3 over dopamine D4,Other,17266201.0,
327,277673,9,1,,103307946,60795,Active,1169206.0,1814.0,0.00447,Ki,Displacement of [3H]spiperone from human dopamine D3 expressed in CHO cell membrane,Confirmatory,17266201.0,
328,277674,9,1,,103307946,60795,Active,1345939.0,1815.0,0.05754,Ki,Displacement of [3H]spiperone from human dopamine D4.4 expressed in CHO cell membrane,Confirmatory,17266201.0,
329,277677,4,1,,103307946,60795,Active,118206.0,1813.0,0.00182,Ki,Binding affinity to dopamine D2,Confirmatory,17266201.0,
330,298478,4,1,,103307946,60795,Active,118206.0,1813.0,0.0050100000000000006,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,Confirmatory,17880057.0,
331,298479,4,1,,103307946,60795,Active,1169206.0,1814.0,0.00398,Ki,Displacement of [3H]spiperone from human dopamine D3 receptor expressed in CHO cells,Confirmatory,17880057.0,
332,298480,4,1,,103307946,60795,Active,1345939.0,1815.0,0.1,Ki,Displacement of [3H]spiperone from human dopamine D4.4 receptor expressed in CHO cells,Confirmatory,17880057.0,
333,298481,4,1,,103307946,60795,Active,231454.0,3350.0,0.007940000000000001,Ki,Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in CHO cells,Confirmatory,17880057.0,
334,298482,4,1,,103307946,60795,Active,543727.0,3356.0,0.01585,Ki,Displacement of [3H]ketanserin from human 5HT2A receptor expressed in CHO cells,Confirmatory,17880057.0,
335,298483,4,1,,103307946,60795,Active,1168220.0,3357.0,0.00126,Ki,Displacement of [3H]LSD from 5HT2B receptor expressed in CHO cells,Confirmatory,17880057.0,
336,298485,4,1,,103307946,60795,Active,112816.0,3358.0,0.05012,Ki,Displacement of [3H]mesulergine from 5HT2C receptor expressed in CHO cells,Confirmatory,17880057.0,
337,298486,4,1,,103307946,60795,Active,1703010.0,3362.0,0.19952999999999999,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
338,298487,4,1,,103307946,60795,Active,8488960.0,3363.0,0.0631,Ki,Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells,Confirmatory,17880057.0,
339,298488,4,1,,103307946,60795,Active,1168222.0,3359.0,0.5011899999999999,Ki,Displacement of [3H]BLR-43694 from human 5HT3 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
340,298488,4,1,,103307946,60795,Active,74705987.0,9177.0,0.5011899999999999,Ki,Displacement of [3H]BLR-43694 from human 5HT3 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
341,298488,4,1,,103307946,60795,Active,162416113.0,285242.0,0.5011899999999999,Ki,Displacement of [3H]BLR-43694 from human 5HT3 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
342,298488,4,1,,103307946,60795,Active,166198366.0,170572.0,0.5011899999999999,Ki,Displacement of [3H]BLR-43694 from human 5HT3 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
343,298488,4,1,,103307946,60795,Active,338817899.0,200909.0,0.5011899999999999,Ki,Displacement of [3H]BLR-43694 from human 5HT3 receptor expressed in HEK293 cells,Confirmatory,17880057.0,
344,298489,4,1,,103307946,60795,Active,400630.0,6532.0,0.03162,Ki,Displacement of [3H]paraxetine from human 5HT transporter expressed in HEK293 cells,Confirmatory,17880057.0,
345,298490,4,1,,103307946,60795,Inactive,113118.0,1128.0,,Ki,Displacement of [3H]pirenzepine from human M1 receptor expressed in CHO cells,Confirmatory,17880057.0,
346,298491,4,1,,103307946,60795,Inactive,23503039.0,1132.0,,Ki,Displacement of [3H]4-DAMP from human M4 receptor expressed in CHO cells,Confirmatory,17880057.0,
347,298492,4,1,,103307946,60795,Active,543734.0,24173.0,0.1,Ki,Displacement of [3H]prazosin from adrenergic alpha1 receptor in rat cerebral cortex,Confirmatory,17880057.0,
348,298492,4,1,,103307946,60795,Active,1168244.0,29413.0,0.1,Ki,Displacement of [3H]prazosin from adrenergic alpha1 receptor in rat cerebral cortex,Confirmatory,17880057.0,
349,298492,4,1,,103307946,60795,Active,1168247.0,29412.0,0.1,Ki,Displacement of [3H]prazosin from adrenergic alpha1 receptor in rat cerebral cortex,Confirmatory,17880057.0,
350,298493,4,1,,103307946,60795,Inactive,231461.0,25083.0,,Ki,Displacement of [3H]RX 821002 from adrenergic alpha-2 receptor in rat cerebral cortex,Confirmatory,17880057.0,
351,298493,4,1,,103307946,60795,Inactive,231464.0,24175.0,,Ki,Displacement of [3H]RX 821002 from adrenergic alpha-2 receptor in rat cerebral cortex,Confirmatory,17880057.0,
352,298493,4,1,,103307946,60795,Inactive,47117345.0,24174.0,,Ki,Displacement of [3H]RX 821002 from adrenergic alpha-2 receptor in rat cerebral cortex,Confirmatory,17880057.0,
353,298494,4,1,,103307946,60795,Active,399889.0,100730517.0,0.1,Ki,Displacement of [3H]pyrilamine from histaminergic H1 receptor guinea pig cerebellum,Confirmatory,17880057.0,
354,301041,6,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in orally dosed Wistar rat assessed as inhibition of conditioned avoidance response after 1 hr,Other,17720494.0,
355,330537,3,4,,103307946,60795,Inactive,,,,,Increase in phospho-AMPK levels in H1RKO mouse hyphalamic slices at 500 nM after 30 mins by Western blotting,Other,17360666.0,
356,330538,3,3,,103307946,60795,Inactive,,,,,Orexigenic activity in H1RKO mouse,Other,17360666.0,
357,330561,8,5,,103307946,60795,Unspecified,399890.0,24448.0,3.0,IC50,Displacement of [3H]mepyramine from H1R in rat brain,Confirmatory,17360666.0,
358,410331,8,5,,103307946,60795,Active,118229.0,24316.0,1.96,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,Confirmatory,19072656.0,
359,410332,8,5,,103307946,60795,Active,47117674.0,24318.0,0.0008,Ki,Displacement of [3H]spiperone from dopamine D2 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,Confirmatory,19072656.0,
360,410333,7,1,,103307946,60795,Active,,,0.0033,Ki,Displacement of [3H]7OH-DPAT from dopamine D3 receptor expressed in Sf9 cells by scintillation spectrometry,Confirmatory,19072656.0,
361,410334,8,5,,103307946,60795,Active,112812.0,24473.0,0.0056,Ki,Displacement of [3H]8OH-DPAT from 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus by scintillation spectrometry,Confirmatory,19072656.0,
362,410335,8,5,,103307946,60795,Active,112808.0,29595.0,0.0087,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in CRL:CD(SD)BR-COBS rat cortex by scintillation spectrometry,Confirmatory,19072656.0,
363,410336,4,3,,103307946,60795,Active,,,0.022000000000000002,Ki,Displacement of [3H]mesulergine from 5HT2C receptor in CRL:(HA) BR albino guinea pig cortex by scintillation spectrometry,Confirmatory,19072656.0,
364,410338,9,5,,103307946,60795,Active,7531135.0,3757.0,1.02,Ki,Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method,Confirmatory,19072656.0,
365,410339,6,2,,103307946,60795,Unspecified,,,,,Sedative activity in NMRI mouse assessed as reduction in spontaneous locomotor activity administered 30 mins prior to testing,Other,19072656.0,
366,410529,6,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in NMRI mouse assessed as reduction in methamphetamine-induced locomotor activity administered 30 mins prior to testing measured for 60 mins,Other,19072656.0,
367,410532,6,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in NMRI mouse assessed as reduction in phencyclidine-induced locomotor activity administered 30 mins prior to testing measured for 60 mins,Other,19072656.0,
368,410535,6,2,,103307946,60795,Unspecified,,,,,Toxicity in sc dosed NMRI mouse assessed as cataleptogenic potential administered 30 mins prior to testing measured every 15 mins for 60 mins by horizontal bar test,Other,19072656.0,
369,434955,1,2,,49666418,60795,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
370,434962,1,2,,49666418,60795,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
371,434973,1,3,,49666418,60795,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
372,434989,1,1,,49666418,60795,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
373,435003,1,3,,49666418,60795,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
374,435005,1,1,,49666418,60795,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
375,435019,1,1,,49666418,60795,Active,,,29.409000000000002,CC50,A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis,Confirmatory,,
376,435022,2,2,,49666418,60795,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
377,435030,1,2,,49666418,60795,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
378,435030,1,2,,49666418,60795,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
379,449728,1,2,,49666418,60795,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
380,449739,1,2,,49681659,60795,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
381,449762,1,2,,49666418,60795,Active,,,13.14,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
382,449763,1,3,,49666418,60795,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
383,449764,1,1,,49666418,60795,Active,,,33.3,IC50,A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol,Confirmatory,,
384,449768,1,1,,49681659,60795,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
385,457687,5,3,,103307946,60795,Active,,,0.001,Ki,Displacement of [3H]nemonapride from D2-like receptor in Wistar rat striatum homogenate,Confirmatory,20153652.0,
386,457688,8,5,,103307946,60795,Active,112812.0,24473.0,0.0004,Ki,Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in Wistar rat hippocampus homogenate,Confirmatory,20153652.0,
387,457689,8,5,,103307946,60795,Active,112808.0,29595.0,0.006999999999999999,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in Wistar rat cortex homogenate,Confirmatory,20153652.0,
388,457690,3,3,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for Wistar rat striatum D2-like receptor to Ki for Wistar rat hippocampus 5HT1A receptor",Other,20153652.0,
389,457691,3,3,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for Wistar rat striatum D2-like receptor to Ki for Wistar rat cortex 5HT2A receptor",Other,20153652.0,
390,457692,3,3,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for Wistar rat hippocampus 5HT1A receptor to Ki for Wistar rat cortex 5HT2A receptor",Other,20153652.0,
391,458630,3,5,,103307946,60795,Unspecified,,,,,"Reduction in 3,4-dihydroxyphenylacetic acid level in Sprague-Dawley rat striatum at 7.68 umol/kg, sc relative to saline treated control",Other,20155917.0,
392,458632,7,5,,103307946,60795,Active,118206.0,1813.0,0.0026,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,Confirmatory,20155917.0,
393,458633,8,5,,103307946,60795,Active,118206.0,1813.0,0.0028,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,Confirmatory,20155917.0,
394,458634,3,9,,103307946,60795,Unspecified,118206.0,1813.0,,,Selectivity ratio of Ki for human dopamine D2 receptor at low affinity state to Ki for human dopamine D2 receptor at high affinity state,Other,20155917.0,
395,458635,3,5,,103307946,60795,Unspecified,,,,,Activity at dopamine D2L receptor expressed in HEK293 cells coexpressing Galphaqi5 assessed as maximal efficacy relative to control,Other,20155917.0,
396,458647,3,5,,103307946,60795,Unspecified,,,,,"Reduction in spontaneous locomotor activity in Sprague-Dawley rat striatum at 7.68 umol/kg, sc relative to control",Other,20155917.0,
397,458652,3,5,,103307946,60795,Unspecified,,,,,"Reduction in amphetamine-induced locomotor activity in Sprague-Dawley rat striatum at 7.68 umol/kg, sc relative to control",Other,20155917.0,
398,463079,1,2,,49666418,60795,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
399,463082,1,1,,49666418,60795,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
400,463104,1,2,,49666418,60795,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
401,463111,1,1,,49666418,60795,Active,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
402,463141,1,2,,49666418,60795,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
403,463165,1,1,,49666418,60795,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
404,463190,1,2,,49666418,60795,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
405,463195,1,2,,49666418,60795,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
406,463210,1,2,,49666418,60795,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
407,463212,1,1,,49666418,60795,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
408,463230,1,2,,49666418,60795,Active,270133071.0,7941.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7),Screening,,
409,463254,1,1,,26719891,60795,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
410,463570,3,6,,103307946,60795,Unspecified,,,,,Partial agonistic activity at dopamine D2 receptor relative to aripiprazole,Other,20153647.0,
411,485270,1,1,,49666418,60795,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
412,485272,1,1,,49666418,60795,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
413,485273,2,1,,49666418,60795,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
414,485275,1,3,,49666418,60795,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
415,485281,1,1,,26719891,60795,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
416,485281,1,1,,29215485,60795,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
417,485290,1,1,,26719891,60795,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
418,485290,1,1,,29215485,60795,Inactive,20150581.0,,39.8107,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
419,485294,1,1,,26719891,60795,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
420,485297,1,1,,26719891,60795,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
421,485298,1,1,,26719891,60795,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
422,485313,1,2,,26719891,60795,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
423,485314,1,1,,26719891,60795,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
424,485317,1,2,,49666418,60795,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
425,485341,1,1,,26719891,60795,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
426,485344,1,1,,26719891,60795,Active,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
427,485346,1,1,,49666418,60795,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
428,485346,1,1,,49666418,60795,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
429,485347,1,2,,26719891,60795,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
430,485353,2,1,,26719891,60795,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
431,485358,1,1,,26719891,60795,Active,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
432,485364,1,1,,26719891,60795,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
433,485367,1,2,,26719891,60795,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
434,488837,1,1,,26719891,60795,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
435,488839,1,1,,49666418,60795,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
436,488839,1,1,,49666418,60795,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
437,488847,1,3,,49666418,60795,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
438,488862,1,1,,49666418,60795,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
439,488890,1,2,,49666418,60795,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
440,488895,1,2,,49666418,60795,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
441,488896,1,1,,49666418,60795,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
442,488899,1,1,,49666418,60795,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
443,488922,1,2,,49666418,60795,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
444,488965,1,2,,49666418,60795,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
445,488966,1,1,,49666418,60795,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
446,488975,1,2,,49666418,60795,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
447,488977,1,2,,49666418,60795,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
448,489028,1,2,,49666418,60795,Inactive,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
449,489028,1,2,,49666418,60795,Inactive,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
450,489030,2,1,,49666418,60795,Active,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
451,489031,2,1,,49666418,60795,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
452,492634,6,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in ip dosed NMRI mouse assessed as reduction in spontaneous exploratory locomotor activity administered 30 mins prior to testing measured for 60 mins,Other,20481570.0,
453,492638,8,5,,103307946,60795,Active,7531135.0,3757.0,1.02,Ki,Binding affinity to human ERG expressed in HEK293 cells,Confirmatory,20481570.0,
454,492639,3,3,,103307946,60795,Active,,,0.022000000000000002,Ki,Displacement of [3H]mesulergine from 5HT2C receptor in CRL:(HA) BR albino guinea pig cortex by scintillation spectrometry,Confirmatory,20481570.0,
455,492640,7,5,,103307946,60795,Active,112808.0,29595.0,0.0087,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in CRL:CD(SD)BR-COBS rat cortex by scintillation spectrometry,Confirmatory,20481570.0,
456,492641,7,5,,103307946,60795,Active,112812.0,24473.0,0.0056,Ki,Displacement of [3H]8OH-DPAT from 5HT1A receptor in rat CRL:CD(SD)BR-COBS hippocampus by scintillation spectrometry,Confirmatory,20481570.0,
457,492642,7,5,,103307946,60795,Active,47117674.0,24318.0,0.0033,Ki,Displacement of [3H]spiperone from dopamine D2 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,Confirmatory,20481570.0,
458,492643,7,5,,103307946,60795,Active,118229.0,24316.0,0.0008,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,Confirmatory,20481570.0,
459,492645,3,3,,103307946,60795,Active,,,,,"Antipsychotic activity in NMRI mouse assessed as increase of PCP-induced locomotor activity at 10 mg/kg, ip administered 30 mins prior to testing measured for 60 mins",Other,20481570.0,
460,492646,3,3,,103307946,60795,Active,,,,,"Antipsychotic activity in NMRI mouse assessed as increase of PCP-induced locomotor activity at 3 mg/kg, ip administered 30 mins prior to testing measured for 60 mins",Other,20481570.0,
461,492947,1,1,,26719891,60795,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
462,492953,1,1,,49666418,60795,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
463,492956,1,1,,49666418,60795,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
464,492961,1,1,,29215485,60795,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
465,492972,1,1,,49666418,60795,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
466,493005,1,1,,49666418,60795,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
467,493008,1,1,,49666418,60795,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
468,493008,1,1,,49666418,60795,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
469,493008,1,1,,49666418,60795,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
470,493008,1,1,,49666418,60795,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
471,493011,1,1,,49666418,60795,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
472,493012,1,1,,49666418,60795,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
473,493014,1,1,,26719891,60795,Inconclusive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
474,493036,1,2,,49666418,60795,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
475,493056,1,1,,26719891,60795,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
476,493084,1,1,,26719891,60795,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
477,493087,1,1,,49666418,60795,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
478,493091,1,1,,49666418,60795,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
479,493098,1,1,,49666418,60795,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
480,493131,1,1,,49666418,60795,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
481,493160,1,1,,49666418,60795,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
482,493187,1,2,,49666418,60795,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
483,493244,1,1,,49666418,60795,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
484,493244,1,1,,49666418,60795,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
485,493244,1,1,,49666418,60795,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
486,493244,1,1,,49666418,60795,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
487,504326,1,2,,49666418,60795,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
488,504326,1,2,,49666418,60795,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
489,504327,1,1,,26719891,60795,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
490,504327,1,1,,29215485,60795,Inconclusive,153791535.0,2648.0,28.1838,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
491,504329,1,1,,49666418,60795,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
492,504332,1,1,,26719891,60795,Inactive,168985070.0,,0.8913,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
493,504332,1,1,,29215485,60795,Inconclusive,168985070.0,,15.8489,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
494,504333,1,1,,26719891,60795,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
495,504339,1,1,,49666418,60795,Inconclusive,162330054.0,,56.2341,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
496,504357,1,1,,49666418,60795,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
497,504357,1,1,,49666418,60795,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
498,504406,1,1,,49666418,60795,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
499,504408,2,1,,49666418,60795,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
500,504411,1,1,,49666418,60795,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
501,504414,1,1,,49666418,60795,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
502,504414,1,1,,49666418,60795,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
503,504423,1,1,,49666418,60795,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
504,504441,1,1,,49666418,60795,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
505,504444,1,1,,49666418,60795,Inconclusive,224028257.0,4780.0,29.0929,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
506,504454,1,3,,49666418,60795,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
507,504462,1,1,,49666418,60795,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
508,504490,1,2,,49666418,60795,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
509,504523,1,1,,49666418,60795,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
510,504523,1,1,,49666418,60795,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
511,504558,1,1,,49666418,60795,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
512,504577,2,2,,49666418,60795,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
513,504582,2,1,,49666418,60795,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
514,504614,1,1,,49666418,60795,Inactive,187952397.0,317.0,,,Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
515,504615,1,1,,49666418,60795,Inactive,187952397.0,317.0,,,uHTS Fluorescent Interference Counterscreen assay for validation of Inhibitors of Apaf-1,Screening,,
516,504621,1,1,,49666418,60795,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
517,504634,1,1,,49666418,60795,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
518,504648,1,1,,49666418,60795,Inconclusive,,,29.0929,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
519,504651,1,1,,26719891,60795,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
520,504652,1,1,,26719891,60795,Active,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
521,504660,1,1,,26719891,60795,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
522,504690,1,3,,49666418,60795,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
523,504692,2,2,,49666418,60795,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
524,504700,1,1,,49666418,60795,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
525,504700,1,1,,49666418,60795,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
526,504707,1,1,,49666418,60795,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
527,504707,1,1,,49666418,60795,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
528,504720,1,1,,49666418,60795,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
529,504734,1,1,,49666418,60795,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
530,504749,1,3,,29215485,60795,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
531,504749,1,3,1.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
532,504749,1,3,2.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
533,504749,1,3,3.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
534,504749,1,3,4.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
535,504749,1,3,5.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
536,504749,1,3,6.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
537,504749,1,3,7.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
538,504749,1,3,8.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
539,504749,1,3,9.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
540,504749,1,3,10.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
541,504749,1,3,11.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
542,504749,1,3,12.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
543,504749,1,3,13.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
544,504749,1,3,14.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
545,504749,1,3,15.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
546,504749,1,3,16.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
547,504749,1,3,17.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
548,504749,1,3,18.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
549,504749,1,3,19.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
550,504749,1,3,20.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
551,504749,1,3,21.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
552,504749,1,3,22.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
553,504749,1,3,23.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
554,504749,1,3,24.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
555,504749,1,3,25.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
556,504749,1,3,26.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
557,504749,1,3,27.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
558,504749,1,3,28.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
559,504749,1,3,29.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
560,504749,1,3,30.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
561,504749,1,3,31.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
562,504749,1,3,32.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
563,504749,1,3,33.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
564,504749,1,3,34.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
565,504749,1,3,35.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
566,504749,1,3,36.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
567,504749,1,3,37.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
568,504749,1,3,38.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
569,504749,1,3,39.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
570,504749,1,3,40.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
571,504749,1,3,41.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
572,504749,1,3,42.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
573,504749,1,3,43.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
574,504749,1,3,44.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
575,504749,1,3,45.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
576,504749,1,3,46.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
577,504749,1,3,47.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
578,504749,1,3,48.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
579,504749,1,3,49.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
580,504749,1,3,50.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
581,504749,1,3,51.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
582,504749,1,3,52.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
583,504749,1,3,53.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
584,504749,1,3,54.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
585,504749,1,3,55.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
586,504749,1,3,56.0,29215485,60795,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
587,504749,1,3,57.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
588,504749,1,3,58.0,29215485,60795,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
589,504749,1,3,59.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
590,504749,1,3,60.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
591,504749,1,3,61.0,29215485,60795,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
592,504766,2,1,,49666418,60795,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
593,504775,1,1,,49666418,60795,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
594,504803,1,1,,49666418,60795,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
595,504810,1,2,,26719891,60795,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
596,504812,1,2,,26719891,60795,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
597,504832,1,1,,29215485,60795,Inconclusive,,,19.0115,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
598,504834,1,1,,29215485,60795,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
599,504842,1,1,,26719891,60795,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
600,504845,1,1,,49666418,60795,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
601,504847,1,1,,29215485,60795,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
602,504847,1,1,,49666418,60795,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
603,504865,1,1,,29215485,60795,Inconclusive,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
604,504884,1,2,,49666418,60795,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
605,504891,1,1,,49666418,60795,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
606,504894,1,1,,49666418,60795,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
607,504937,1,2,,49666418,60795,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
608,516803,6,5,,103307946,60795,Active,7531135.0,3757.0,0.598,Ki,Displacement of [3H]dofetilide from human ERG,Confirmatory,20801650.0,
609,516804,6,5,,103307946,60795,Active,118206.0,1813.0,0.004,Ki,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,Confirmatory,20801650.0,
610,516805,6,5,,103307946,60795,Active,543727.0,3356.0,0.004,Ki,Binding affinity to human 5HT2A receptor,Confirmatory,20801650.0,
611,516806,6,5,,103307946,60795,Active,231454.0,3350.0,0.006999999999999999,Ki,Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HeLa cells,Confirmatory,20801650.0,
612,516809,2,10,,103307946,60795,Unspecified,118206.0,1813.0,,,Intrinsic activity at human dopamine D2L receptor expressed in CHO cells by FLIPR assay relative to quinpirole,Other,20801650.0,
613,516811,2,10,,103307946,60795,Unspecified,231454.0,3350.0,,,Intrinsic activity at human dopamine 5HT1A receptor expressed in HeLa cells by FLIPR assay,Other,20801650.0,
614,516812,1,3,,103307946,60795,Unspecified,,,,,"In vivo intrinsic activity at D2 receptor in mouse brain assessed as inhibition of gamma-butyrolactone-induced increase in DOPA synthesis at 30 mg/kg, po administered 60 mins before gamma-butyrolactone challenge measured after 30 mins",Other,20801650.0,
615,516816,1,3,,103307946,60795,Unspecified,,,,,Antipsychotic activity in po dosed mouse assessed as inhibition of spontaneous locomotor activity,Other,20801650.0,
616,516817,2,3,,103307946,60795,Unspecified,,,,,Selectivity ratio of Ki for human dopamine D2L receptor to Ki for human 5HT2A receptor,Other,20801650.0,
617,516818,5,2,,103307946,60795,Unspecified,,,,,Apparent intrinsic clearance in human liver microsomes,Other,20801650.0,
618,516820,1,3,,103307946,60795,Unspecified,,,,,"Induction of catalepsy in mouse at 30 mg/kg, po",Other,20801650.0,
619,516825,1,4,,103307946,60795,Unspecified,,,,,Ex vivo D2 receptor occupancy in po dosed rat striatum assessed as inhibition [3H]-raclopride binding at 21 ng/ml plasma concentration,Other,20801650.0,
620,516826,1,4,,103307946,60795,Unspecified,,,,,Ex vivo D2 receptor occupancy in po dosed rat striatum assessed as inhibition [3H]-raclopride binding at 158 ng/ml plasma concentration,Other,20801650.0,
621,539464,4,2,,103307946,60795,Active,,,,,Solubility of the compound in 0.1 M phosphate buffer at 600 uM at pH 7.4 after 24 hrs by LC/MS/MS analysis,Other,21055935.0,
622,539465,4,4,,103307946,60795,Active,,,1.0,IC50,Inhibition of human ERG,Confirmatory,21055935.0,
623,540209,4,3,,103307946,60795,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
624,540210,4,3,,103307946,60795,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
625,540211,2,5,,103307946,60795,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
626,540212,4,3,,103307946,60795,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
627,540213,4,3,,103307946,60795,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
628,540253,1,1,,49666418,60795,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
629,540253,1,1,,49666418,60795,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
630,540253,1,1,,49666418,60795,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
631,540263,1,1,,49666418,60795,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
632,540263,1,1,,49666418,60795,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
633,540267,1,1,,49666418,60795,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
634,540275,1,1,,26719891,60795,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
635,540277,1,1,,26719891,60795,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
636,540295,1,1,,49666418,60795,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
637,540303,1,1,,49666418,60795,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
638,540303,1,1,,49666418,60795,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
639,540303,1,1,,49666418,60795,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
640,540308,1,1,,49666418,60795,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
641,540317,1,1,,49666418,60795,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
642,540336,1,1,,49666418,60795,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
643,540336,1,1,,49666418,60795,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
644,540364,1,2,,49666418,60795,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
645,576612,7,5,,103307946,60795,Active,7531135.0,3757.0,0.6309600000000001,IC50,Inhibition of human ERG,Confirmatory,21185626.0,
646,588334,1,1,,49666418,60795,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
647,588335,1,1,,49666418,60795,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
648,588342,1,1,,26719891,60795,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
649,588352,1,2,,49666418,60795,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
650,588354,1,1,,49666418,60795,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
651,588358,1,2,,49666418,60795,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
652,588391,1,1,,49666418,60795,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
653,588405,1,1,,49666418,60795,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
654,588413,1,2,,49666418,60795,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
655,588436,1,1,,49666418,60795,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
656,588453,1,1,,49666418,60795,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
657,588456,1,1,,49666418,60795,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
658,588458,1,1,,49666418,60795,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
659,588473,1,1,,49666418,60795,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
660,588473,1,1,,49666418,60795,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
661,588475,1,2,,49666418,60795,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
662,588475,1,2,,49666418,60795,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
663,588478,1,2,,124799564,60795,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
664,588489,1,1,,49666418,60795,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
665,588492,1,1,,49666418,60795,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
666,588493,1,2,,49666418,60795,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
667,588497,1,2,,49666418,60795,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
668,588497,1,2,,49666418,60795,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
669,588497,1,2,,49666418,60795,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
670,588499,1,3,,49666418,60795,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
671,588499,1,3,,49666418,60795,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
672,588499,1,3,,49666418,60795,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
673,588501,1,2,,49666418,60795,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
674,588501,1,2,,49666418,60795,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
675,588501,1,2,,49666418,60795,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
676,588511,1,2,,49666418,60795,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
677,588549,1,1,,49666418,60795,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
678,588579,1,1,,29215485,60795,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
679,588579,1,1,,49666418,60795,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
680,588590,1,1,,49666418,60795,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
681,588591,1,1,,49666418,60795,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
682,588621,1,1,,49666418,60795,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
683,588627,1,1,,49666418,60795,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
684,588664,1,2,,49666418,60795,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
685,588664,1,2,,49666418,60795,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
686,588674,1,2,,49666418,60795,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
687,588675,1,1,,49666418,60795,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
688,588676,1,1,,49666418,60795,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
689,588689,1,1,,49666418,60795,Inconclusive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
690,588692,2,1,,49666418,60795,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
691,588726,1,2,,49666418,60795,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
692,588727,1,1,,49666418,60795,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
693,588795,1,1,,49666418,60795,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
694,588814,1,3,,49666418,60795,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
695,588819,1,4,,49666418,60795,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
696,588834,2,1,,144205281,60795,Active,325651834.0,3757.0,1.7783,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
697,588850,1,1,,49666418,60795,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
698,588852,1,3,,49666418,60795,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
699,588855,1,1,,49666418,60795,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
700,588856,1,1,,49666418,60795,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
701,589038,1,10,,103307946,60795,Unspecified,84028191.0,1565.0,,,"Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP2D6",Other,,
702,595494,1,10,,103307946,60795,Unspecified,118206.0,1813.0,,,Intrinsic activity at human dopamine D2 receptor expressed in CHO cells by [3H]-thymidine uptake assay relative to quinpirole,Other,21353774.0,
703,595495,5,5,,103307946,60795,Active,118206.0,1813.0,0.0018,Ki,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,Confirmatory,21353774.0,
704,595497,5,5,,103307946,60795,Active,543727.0,3356.0,0.0096,Ki,Binding affinity to human 5HT2A receptor,Confirmatory,21353774.0,
705,595498,5,5,,103307946,60795,Active,231454.0,3350.0,0.0103,Ki,Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HeLa cells,Confirmatory,21353774.0,
706,595499,1,3,,103307946,60795,Unspecified,,,,,In vivo intrinsic activity at D2 receptor in po dosed mouse brain assessed as inhibition of gamma-butyrolactone-induced increase in DOPA synthesis,Other,21353774.0,
707,595501,1,3,,103307946,60795,Unspecified,,,,,Antipsychotic activity in po dosed mouse assessed as inhibition of spontaneous locomotor activity,Other,21353774.0,
708,595503,1,3,,103307946,60795,Unspecified,,,,,Induction of catalepsy in mouse,Other,21353774.0,
709,595504,1,3,,103307946,60795,Unspecified,,,,,"In vivo antagonist activity at 5-HT2A receptor in rat assessed as inhibition of 2,5-dimethoxy-4-iodoamphetamine-induced head twitch at 3 x sLMA MED",Other,21353774.0,
710,595520,1,3,,103307946,60795,Unspecified,,,,,Ratio of MED for catalepsy induction to in mouse to MED for inhibition of spontaneous locomotor activity in mouse,Other,21353774.0,
711,598251,10,2,,103307946,60795,Active,238054374.0,5243.0,0.78,IC50,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 after 20 mins by FACS analysis,Confirmatory,21341745.0,
712,598252,1,11,,103307946,60795,Unspecified,238054374.0,5243.0,,,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 at 0.1 mM after 20 mins by FACS analysis relative to 5 mM sodium orthovanadate,Other,21341745.0,
713,599883,5,5,,103307946,60795,Active,112816.0,3358.0,0.022000000000000002,Ki,Displacement of [3H]mesulergine from human 5HT2C receptor in human tsA201 cells,Confirmatory,20719507.0,
714,599884,5,5,,103307946,60795,Active,1703010.0,3362.0,0.574,Ki,Displacement of [3H]5-LSD from human 5HT6 receptor expressed in human HeLa cells,Confirmatory,20719507.0,
715,602123,1,1,,49666418,60795,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
716,602141,1,1,,49666418,60795,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
717,602162,1,1,,49666418,60795,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
718,602163,1,1,,49666418,60795,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
719,602179,1,2,,49666418,60795,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
720,602229,1,1,,49666418,60795,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
721,602233,1,1,,49666418,60795,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
722,602244,1,2,,49666418,60795,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
723,602247,1,2,,49666418,60795,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
724,602248,1,2,,49666418,60795,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
725,602250,1,2,,49666418,60795,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
726,602252,1,1,,49666418,60795,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
727,602252,1,1,,49666418,60795,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
728,602261,1,1,,49666418,60795,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
729,602274,1,2,,49666418,60795,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
730,602281,1,1,,49666418,60795,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
731,602281,1,1,,49666418,60795,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
732,602282,1,1,,49666418,60795,Active,5032039.0,5999.0,,,Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4),Screening,,
733,602283,1,1,,49666418,60795,Active,,,,,Counter screen for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay,Screening,,
734,602310,1,2,,49666418,60795,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
735,602313,1,1,,49666418,60795,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
736,602329,1,1,,49666418,60795,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
737,602332,1,1,,29215485,60795,Inconclusive,168984549.0,,50.1187,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
738,602332,1,1,,49666418,60795,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
739,602340,1,2,,49666418,60795,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
740,602342,2,1,,49666418,60795,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
741,602346,1,1,,49666418,60795,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
742,602363,1,1,,49666418,60795,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
743,602393,1,1,,49666418,60795,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
744,602396,1,2,,49666418,60795,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
745,602399,1,2,,49666418,60795,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
746,602405,1,1,,49666418,60795,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
747,602410,1,1,,49666418,60795,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
748,602429,1,1,,49666418,60795,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
749,602438,1,1,,49666418,60795,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
750,602440,1,1,,49666418,60795,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
751,602449,1,2,,49666418,60795,Active,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
752,602481,1,1,,49666418,60795,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
753,610678,5,5,,103307946,60795,Active,118206.0,1813.0,0.0031,Ki,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,Confirmatory,21536445.0,
754,610679,5,5,,103307946,60795,Active,1169206.0,1814.0,0.0068,Ki,Displacement of [125I]ABN from human recombinant D3 receptor expressed in HEK cells after 60 mins by gamma counter,Confirmatory,21536445.0,
755,610680,5,5,,103307946,60795,Active,1345939.0,1815.0,0.168,Ki,Displacement of [125I]ABN from human recombinant D4 receptor expressed in HEK cells after 60 mins by gamma counter,Confirmatory,21536445.0,
756,610681,1,4,,103307946,60795,Unspecified,,,,,Selectivity ratio of Ki for human recombinant D3 receptor to Ki for human recombinant D2L receptor,Other,21536445.0,
757,610682,1,4,,103307946,60795,Unspecified,,,,,Selectivity ratio of Ki for human recombinant D4 receptor to Ki for human recombinant D2L receptor,Other,21536445.0,
758,610683,5,5,,103307946,60795,Inconclusive,81862796.0,100135589.0,,Ki,Displacement of [3H](+)-pentazocine from guinea pig brain sigma-1 receptor after 90 mins by liquid scintillation counter,Confirmatory,21536445.0,
759,610684,1,4,,103307946,60795,Inconclusive,,,,Ki,Displacement of [3H]DTG from rat liver sigma-2 receptor in presence of (+)-pentazocine after 120 mins by liquid scintillation counter,Confirmatory,21536445.0,
760,616780,4,3,,103307946,60795,Active,,,0.098,Ki,Binding affinity to SERT,Confirmatory,21823597.0,
761,616781,4,2,,103307946,60795,Active,,,0.0008,Ki,Binding affinity to 5-HT2A,Confirmatory,21823597.0,
762,623870,1,1,,49666418,60795,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
763,623870,1,1,,49666418,60795,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
764,623877,1,1,,49666418,60795,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
765,623901,1,1,,49666418,60795,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
766,624030,1,2,,29215485,60795,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
767,624031,1,2,,29215485,60795,Active,,,32.1968,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
768,624032,1,2,,29215485,60795,Active,8393992.0,24660.0,22.7936,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
769,624037,1,3,,49666418,60795,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
770,624038,1,3,,49666418,60795,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
771,624040,1,3,,49666418,60795,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
772,624044,1,2,,29215485,60795,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
773,624125,1,4,,49666418,60795,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
774,624126,1,3,,49666418,60795,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
775,624127,1,2,,49666418,60795,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
776,624168,1,1,,49666418,60795,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
777,624169,1,1,,49666418,60795,Active,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
778,624170,1,1,,29215485,60795,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
779,624170,1,1,,49666418,60795,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
780,624171,1,1,,49666418,60795,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
781,624172,1,1,,29215485,60795,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
782,624172,1,1,,49666418,60795,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
783,624173,1,3,,29215485,60795,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
784,624173,1,3,,49666418,60795,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
785,624178,1,1,,49666418,60795,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
786,624185,1,1,,135649956,60795,Active,12621102.0,65032.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT7,Other,10327430.0,
787,624189,1,1,,135649956,60795,Active,13242259.0,64354.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT6,Other,10327430.0,
788,624199,1,1,,135649956,60795,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,12784105.0,
789,624202,1,1,,49666418,60795,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
790,624204,1,2,,49666418,60795,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
791,624210,1,1,,135649956,60795,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,12784105.0,
792,624211,1,1,,135649956,60795,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,12784105.0,
793,624216,2,1,,135649956,60795,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,12629531.0,
794,624234,1,1,,135649956,60795,Active,8393583.0,29595.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2A,Other,12784105.0,
795,624235,2,1,,135649956,60795,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,12629531.0,
796,624235,2,1,,135649956,60795,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,12784105.0,
797,624246,1,1,,49666418,60795,Inconclusive,343478176.0,2078.0,7.9433,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
798,624256,1,2,,49666418,60795,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
799,624263,1,1,,49666418,60795,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
800,624263,1,1,,49666418,60795,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
801,624267,1,2,,49666418,60795,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
802,624267,1,2,,49666418,60795,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
803,624268,1,3,,49666418,60795,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
804,624288,1,1,,49666418,60795,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
805,624296,1,1,,29215485,60795,Inconclusive,7705682.0,51053.0,13.3359,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
806,624296,1,1,,49666418,60795,Inactive,7705682.0,51053.0,0.4611,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
807,624297,1,1,,29215485,60795,Inconclusive,7705682.0,51053.0,33.4983,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
808,624297,1,1,,49666418,60795,Inconclusive,7705682.0,51053.0,7.0795,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
809,624304,1,2,,49666418,60795,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
810,624330,1,2,,49666418,60795,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
811,624349,1,2,,92307952,60795,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
812,624349,1,2,,92308408,60795,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
813,624349,1,2,,92308936,60795,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
814,624352,1,1,,49666418,60795,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
815,624354,1,1,,49666418,60795,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
816,624377,1,1,,49666283,60795,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
817,624380,1,1,,49666418,60795,Inactive,117940060.0,4988.0,,,Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput screening assay to identify agonists of the mu 1 opioid receptor (OPRM1),Screening,,
818,624381,1,1,,49666418,60795,Active,27753985.0,15558.0,,,Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
819,624414,1,1,,49666418,60795,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
820,624415,1,2,,49666418,60795,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
821,624416,1,1,,49666283,60795,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
822,624417,1,1,,49666418,60795,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
823,624418,1,1,,49666418,60795,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
824,624463,1,1,,49666418,60795,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
825,624464,1,1,,49666418,60795,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
826,624465,1,1,,49666418,60795,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
827,624466,1,3,,49666283,60795,Active,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
828,624467,1,1,,49666283,60795,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
829,624483,1,1,,49666418,60795,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
830,624499,1,1,,49666418,60795,Inactive,117940060.0,4988.0,92.469,EC50,Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1),Confirmatory,,
831,624503,1,1,,49666418,60795,Active,27753985.0,15558.0,8.392999999999999,EC50,Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Confirmatory,,
832,624504,1,1,,49666418,60795,Active,,,,,Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay,Screening,,
833,625279,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
834,625280,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
835,625281,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
836,625282,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
837,625283,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
838,625284,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
839,625285,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
840,625286,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
841,625287,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
842,625288,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
843,625289,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
844,625290,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
845,625291,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
846,625292,1,3,,103307946,60795,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
847,651550,1,1,,49666418,60795,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
848,651560,1,1,,49666418,60795,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
849,651572,1,2,,49666283,60795,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
850,651582,1,1,,49666418,60795,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
851,651602,1,1,,49666283,60795,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
852,651602,1,1,,49666283,60795,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
853,651602,1,1,,49666283,60795,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
854,651610,2,1,,49666283,60795,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
855,651631,4,1,,144205281,60795,Inconclusive,269849759.0,7157.0,29.8493,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
856,651632,4,1,,144205281,60795,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
857,651633,4,1,,144205281,60795,Active,,,23.7101,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
858,651634,4,1,,144205281,60795,Inactive,,,33.4915,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
859,651635,1,3,,49666418,60795,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
860,651636,1,1,,49666418,60795,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
861,651640,1,1,,49666283,60795,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
862,651644,1,1,,49666418,60795,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
863,651647,1,1,,49666418,60795,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
864,651654,1,1,,49666418,60795,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
865,651658,1,1,,49666283,60795,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
866,651661,2,1,,49666283,60795,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
867,651687,1,1,,49666418,60795,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
868,651699,1,1,,49666418,60795,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
869,651699,1,1,,49666418,60795,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
870,651702,1,2,,49666418,60795,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
871,651704,2,1,,49666283,60795,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
872,651710,1,1,,49666283,60795,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
873,651711,2,1,,49666283,60795,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
874,651718,1,2,,49666283,60795,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
875,651719,1,2,,49666283,60795,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
876,651723,1,1,,49666418,60795,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
877,651724,1,1,,49666418,60795,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
878,651725,1,1,,49666418,60795,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
879,651768,1,2,,49666418,60795,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
880,651780,2,2,,49666283,60795,Active,156104883.0,2769.0,,,Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective antagonists,Screening,,
881,651785,2,2,,49666283,60795,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
882,651800,1,1,,49666283,60795,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
883,651819,1,1,,49666418,60795,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
884,651820,1,1,,49666418,60795,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
885,651821,2,4,,49666283,60795,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
886,651828,1,2,,92308408,60795,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
887,651828,1,2,,92308936,60795,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
888,651953,1,3,,49666283,60795,Active,156104883.0,2769.0,,,Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective Ga16 agonists,Screening,,
889,651955,1,2,,49666283,60795,Inactive,21264324.0,134864.0,,,Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify TAAR1 Agonists,Screening,,
890,651957,1,1,,49666283,60795,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
891,651958,1,1,,49666283,60795,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
892,651965,1,1,,49666418,60795,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
893,651999,1,1,,49666418,60795,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
894,652010,1,1,,49666283,60795,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
895,652017,1,1,,49666283,60795,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
896,652025,1,1,,49666418,60795,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
897,652039,1,1,,49666283,60795,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
898,652048,1,2,,49666418,60795,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
899,652048,1,2,,144205281,60795,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
900,652051,1,1,,49666418,60795,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
901,652051,1,1,,144205281,60795,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
902,652054,1,1,,49666418,60795,Active,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
903,652067,1,4,,49666283,60795,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
904,652104,1,1,,49666418,60795,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
905,652105,1,1,,49666418,60795,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
906,652106,1,1,,49666418,60795,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
907,652115,1,1,,49666283,60795,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
908,652126,1,3,,49666283,60795,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
909,652154,1,1,,49666283,60795,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
910,652162,2,1,,49666283,60795,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
911,652163,1,1,,49666283,60795,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
912,652197,1,1,,49666283,60795,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
913,652257,1,1,,49666283,60795,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
914,669779,1,8,,103307946,60795,Unspecified,60392839.0,,,,Inhibition of norA-mediated ethidium bromide efflux in Staphylococcus aureus SA-1199B harboring grlA A116E mutant at 50 uM after 5 mins by fluorometric analysis,Other,24900460.0,
915,669781,1,8,,103307946,60795,Unspecified,238054374.0,5243.0,,,Inhibition of human recombinant MDR1 expressed in mouse L5178Y cells assessed as inhibition of rhodamine-123 efflux at 10'-4 M preincubated for 10 mins measured after 20 mins by FACS analysis,Other,24900460.0,
916,669782,2,3,,103307946,60795,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus SA-1199B harboring grlA A116E mutant by microdilution techniques,Other,24900460.0,
917,686940,1,1,,49666283,60795,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
918,686964,1,1,,49666283,60795,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
919,686970,1,2,,49666418,60795,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
920,686971,1,2,,49666418,60795,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
921,686978,1,1,,49666418,60795,Active,79154014.0,55775.0,14.581,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
922,686978,1,1,,144205281,60795,Inconclusive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
923,686979,1,1,,49666418,60795,Active,79154014.0,55775.0,16.3601,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
924,686979,1,1,,144205281,60795,Inconclusive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
925,686992,2,1,,49666283,60795,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
926,686996,1,1,,49666283,60795,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
927,687014,1,1,,49666283,60795,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
928,687016,1,1,,49666283,60795,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
929,698934,1,7,,103307946,60795,Unspecified,118206.0,1813.0,,,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay relative to Quinpirole,Other,22845053.0,
930,698935,2,6,,103307946,60795,Active,118206.0,1813.0,0.004,EC50,Agonist activity at D2L receptor in human HTLA cells assessed as beta arrestin recruitment at 6 uM after 18 hrs by luminescence assay,Confirmatory,22845053.0,
931,698936,1,7,,103307946,60795,Unspecified,118206.0,1813.0,,,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay relative to quinpirole,Other,22845053.0,
932,698937,2,6,,103307946,60795,Active,118206.0,1813.0,0.001,EC50,Agonist activity at human D2L receptor expressed in HEK293T cells coexpressing Gi subunit assessed as inhibition of isoproterenol-stimulated cAMP production by luminescence assay,Confirmatory,22845053.0,
933,698938,3,5,,103307946,60795,Active,118206.0,1813.0,0.0039,Ki,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,Confirmatory,22845053.0,
934,705591,1,2,,103307946,60795,Unspecified,,,,,"Lipophilicity, log D of the compound",Other,22409598.0,
935,705598,1,3,,103307946,60795,Unspecified,,,,,Oral bioavailability in human,Other,22409598.0,
936,705599,2,3,,103307946,60795,Unspecified,,,,,Clearance in human,Other,22409598.0,
937,705600,1,2,,103307946,60795,Unspecified,,,,,Half life in human,Other,22409598.0,
938,720504,1,1,,49666418,60795,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
939,720508,1,1,,49666283,60795,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
940,720509,1,1,,49666283,60795,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
941,720511,1,1,,49666283,60795,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
942,720516,2,1,,144205281,60795,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
943,720532,1,1,,144205281,60795,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
944,720533,1,1,,144205281,60795,Inconclusive,,,39.8107,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
945,720542,1,2,,49666418,60795,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
946,720543,1,1,,49666283,60795,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
947,720551,1,2,,49666418,60795,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
948,720552,2,1,,144205281,60795,Inconclusive,269849759.0,7157.0,33.4915,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
949,720553,1,2,,49666418,60795,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
950,720554,1,3,,92308408,60795,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
951,720579,2,1,,49666418,60795,Inconclusive,222762.0,3707576.0,14.1254,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
952,720580,1,1,,49666418,60795,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
953,720582,1,1,,49666283,60795,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
954,720596,1,1,,49666283,60795,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
955,720634,2,1,,144205281,60795,Inconclusive,,,1.3333,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
956,720635,2,1,,144205281,60795,Inconclusive,,,5.9557,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
957,720637,2,1,,144205281,60795,Inconclusive,,,5.9557199999999995,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
958,720641,1,2,,92307952,60795,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
959,720641,1,2,,92308408,60795,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
960,720641,1,2,,92308936,60795,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
961,720647,1,2,,49666283,60795,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
962,720648,1,1,,49666283,60795,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
963,720674,2,2,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
964,720675,2,2,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
965,720678,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
966,720679,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
967,720680,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
968,720681,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
969,720682,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
970,720683,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
971,720684,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
972,720685,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
973,720686,2,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
974,720687,2,2,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
975,720691,4,1,,144205281,60795,Inactive,311348376.0,2908.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
976,720692,3,1,,144205281,60795,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
977,720693,3,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
978,720700,1,4,,49666283,60795,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
979,720702,1,1,,49666283,60795,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
980,720704,1,4,,49666283,60795,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
981,720707,1,2,,49666418,60795,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
982,720708,1,2,,49666418,60795,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
983,720709,1,2,,49666418,60795,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
984,720711,1,2,,49666418,60795,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
985,720717,1,3,,92307952,60795,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
986,720717,1,3,,92308408,60795,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
987,720717,1,3,,92308936,60795,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
988,720719,2,1,,144205281,60795,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
989,720725,2,1,,144205281,60795,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
990,721751,2,5,,103307946,60795,Unspecified,313104182.0,6582.0,239.0,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,Confirmatory,23241029.0,
991,721752,2,5,,103307946,60795,Unspecified,74727585.0,146802.0,500.0,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,Confirmatory,23241029.0,
992,721754,2,5,,103307946,60795,Unspecified,74731723.0,55244.0,130.0,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,Confirmatory,23241029.0,
993,722917,2,5,,103307946,60795,Active,1169206.0,1814.0,0.0097,Ki,Displacement of [3H]-methylspiperone from human dopamine D3 receptor expressed in HEK293 after 1 hr,Confirmatory,23279866.0,
994,722918,1,2,,103307946,60795,Unspecified,,,,,"Toxicity in CD1 mouse assessed as induction of sedation at 1 mg/kg, ip",Other,23279866.0,
995,722919,1,2,,103307946,60795,Active,,,,,"Antipsychotic activity in CD1 mouse assessed as inhibition MK-801-evoked hyperactivity at 0.5 mg/kg, ip after 30 mins",Other,23279866.0,
996,723168,1,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in ip dosed Swiss albino mouse assessed as inhibition of (+/-)DOI-induced head twitch response after 20 mins,Other,23279866.0,
997,723169,1,2,,103307946,60795,Unspecified,,,,,Antipsychotic activity in ip dosed Swiss albino mouse assessed as inhibition of apomorphine-induced climbing behavior administered 10 mins before apomorphine-challenge measured after 2 mins,Other,23279866.0,
998,723174,1,2,,103307946,60795,Unspecified,,,,,"Antipsychotic activity in Swiss albino mouse assessed as inhibition of apomorphine-induced climbing behavior at 1 mg/kg, ip administered 10 mins before apomorphine-challenge measured after 2 mins",Other,23279866.0,
999,723175,2,5,,103307946,60795,Active,400629.0,25553.0,1.08,Ki,Displacement of [3H]-citalopram from SERT in rat cerebral cortex after 1 hr by scintillation counting,Confirmatory,23279866.0,
1000,723177,1,2,,103307946,60795,Active,,,0.0257,Ki,Displacement of [3H]-Prazosin from adrenergic alpha1 receptor in rat cortex after 30 mins by scintillation counting,Confirmatory,23279866.0,
1001,723179,2,5,,103307946,60795,Active,118206.0,1813.0,0.0008,Ki,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,Confirmatory,23279866.0,
1002,723181,2,5,,103307946,60795,Active,1703010.0,3362.0,0.09,Ki,Displacement of [3H]-LSD from human 5HT6 receptor expressed in HEK293 after 1 hr,Confirmatory,23279866.0,
1003,723182,2,5,,103307946,60795,Active,8488960.0,3363.0,0.026000000000000002,Ki,Displacement of [3H]-5-CT from human 5HT7 receptor expressed in HEK293 after 1 hr,Confirmatory,23279866.0,
1004,723183,2,5,,103307946,60795,Active,543727.0,3356.0,0.021,Ki,Displacement of [3H]-ketanserin from human 5HT2A receptor expressed in HEK293 after 1.5 hrs,Confirmatory,23279866.0,
1005,723184,2,5,,103307946,60795,Active,231454.0,3350.0,0.0056,Ki,Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HEK293 after 1 hr,Confirmatory,23279866.0,
1006,727074,5,1,,103307946,60795,Active,118206.0,1813.0,0.0076,IC50,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,Confirmatory,23237836.0,
1007,727075,4,2,,103307946,60795,Active,118206.0,1813.0,0.0002,Ki,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,Confirmatory,23237836.0,
1008,727076,1,6,,103307946,60795,Unspecified,118206.0,1813.0,,,Intrinsic agonist activity at human D2 dopamine receptor expressed in CHO cell membrane using cellular CD spectroscopy by Cell-Key assay,Other,23237836.0,
1009,742761,3,2,,103307946,60795,Active,118206.0,1813.0,,,Dopamine D2 receptor partial agonist,Other,,
1010,742855,2,2,,103307946,60795,Active,231454.0,3350.0,,,Serotonin 1a (5-HT1a) receptor partial agonist,Other,,
1011,742882,2,2,,103307946,60795,Active,543727.0,3356.0,,,Serotonin 2a (5-HT2a) receptor antagonist,Other,,
1012,743012,3,1,,144205281,60795,Active,,,5.9557,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1013,743014,3,1,,144205281,60795,Active,,,5.308,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1014,743015,3,1,,144205281,60795,Active,,,6.6824,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1015,743033,3,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1016,743035,2,1,,144205281,60795,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1017,743036,2,1,,144205281,60795,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1018,743040,3,1,,144205281,60795,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1019,743041,3,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1020,743042,3,1,,144205281,60795,Inconclusive,124375976.0,367.0,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1021,743053,2,1,,144205281,60795,Inconclusive,124375976.0,367.0,26.8325,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1022,743054,2,1,,144205281,60795,Inconclusive,124375976.0,367.0,10.5909,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1023,743063,2,1,,144205281,60795,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1024,743064,3,1,,144205281,60795,Active,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1025,743065,3,1,,144205281,60795,Active,399498506.0,24831.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1026,743066,3,1,,144205281,60795,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1027,743067,2,1,,144205281,60795,Inconclusive,399498506.0,24831.0,11.4358,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1028,743069,2,1,,144205281,60795,Inconclusive,348019627.0,2099.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1029,743074,2,1,,144205281,60795,Active,,,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1030,743075,2,1,,144205281,60795,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1031,743077,2,1,,144205281,60795,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1032,743078,2,1,,144205281,60795,Inconclusive,348019627.0,2099.0,23.9145,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1033,743079,3,1,,144205281,60795,Inconclusive,348019627.0,2099.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1034,743080,3,1,,144205281,60795,Inconclusive,348019627.0,2099.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1035,743081,3,1,,144205281,60795,Inconclusive,,,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1036,743083,3,1,,144205281,60795,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1037,743084,3,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1038,743085,3,1,,144205281,60795,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1039,743086,3,1,,144205281,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1040,743091,2,1,,144205281,60795,Inconclusive,348019627.0,2099.0,24.6377,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1041,743094,3,1,,144205281,60795,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1042,743122,2,1,,144205281,60795,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1043,743126,1,1,,49666283,60795,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1044,743139,2,1,,144205281,60795,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1045,743140,2,1,,144205281,60795,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1046,743191,3,1,,170465392,60795,Inconclusive,216409692.0,5468.0,26.6011,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1047,743194,3,1,,170465392,60795,Active,,,14.9589,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1048,743199,2,1,,170465392,60795,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1049,743202,4,1,,170465392,60795,Inconclusive,20149576.0,4780.0,13.3322,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1050,743203,3,1,,170465392,60795,Active,,,16.7842,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1051,743209,3,1,,170465392,60795,Active,,,26.6011,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1052,743210,4,1,,170465392,60795,Inconclusive,4504517.0,3315.0,29.846999999999998,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1053,743211,3,1,,170465392,60795,Active,,,11.8823,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1054,743212,3,1,,170465392,60795,Inconclusive,216409690.0,5467.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1055,743213,3,1,,170465392,60795,Active,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1056,743215,3,1,,170465392,60795,Inconclusive,216409690.0,5467.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1057,743217,3,1,,170465392,60795,Inconclusive,325495553.0,9971.0,21.13,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1058,743218,3,1,,170465392,60795,Active,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1059,743219,3,1,,170465392,60795,Inconclusive,20149576.0,4780.0,18.8322,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1060,743220,3,1,,170465392,60795,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1061,743221,3,1,,170465392,60795,Active,,,16.7842,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1062,743222,3,1,,170465392,60795,Inconclusive,216409708.0,7421.0,33.4889,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1063,743223,3,1,,170465392,60795,Inconclusive,216409708.0,7421.0,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1064,743224,3,1,,170465392,60795,Active,,,11.8823,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1065,743225,3,1,,170465392,60795,Active,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1066,743226,2,1,,170465392,60795,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1067,743227,2,1,,170465392,60795,Inconclusive,216409690.0,5467.0,7.4972199999999996,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1068,743228,3,1,,170465392,60795,Inconclusive,4504517.0,3315.0,29.846999999999998,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1069,743238,1,1,,49666283,60795,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1070,743239,2,1,,170465392,60795,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1071,743240,2,1,,170465392,60795,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1072,743241,2,1,,170465392,60795,Inconclusive,216409708.0,7421.0,26.6011,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1073,743242,2,1,,170465392,60795,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1074,743244,1,1,,144205281,60795,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1075,743247,1,2,,49666283,60795,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1076,743255,1,1,,49666418,60795,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1077,743266,1,2,,49666418,60795,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1078,743268,1,1,,172080264,60795,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
1079,743269,1,1,,49666283,60795,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1080,743269,1,1,,49666283,60795,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1081,743270,1,1,,172080264,60795,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1082,743271,1,1,,172080264,60795,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
1083,743272,1,1,,172080264,60795,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
1084,743279,1,2,,49666418,60795,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1085,743281,1,1,,46386763,60795,Inactive,1778357.0,22341.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
1086,743281,1,1,,46386763,60795,Inactive,219520294.0,8828.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
1087,743344,1,1,,174006897,60795,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1088,743345,1,1,,174006897,60795,Inactive,,,21.1177,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1089,743346,1,1,,174006897,60795,Inactive,,,16.7744,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1090,743347,1,1,,174006897,60795,Inactive,,,14.9502,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1091,743397,1,1,,49666283,60795,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1092,743398,1,1,,49666283,60795,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1093,1053175,2,1,,178126986,60795,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1094,1053197,1,1,,49666283,60795,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1095,1071695,1,1,,103307946,60795,Unspecified,,,,,"Induction of catalepsy in albino mouse at 15 mg/kg, ip relative to control",Other,24486417.0,
1096,1071696,1,1,,103307946,60795,Unspecified,,,,,"Antiserotogenic activity in albino mouse assessed as inhibition of 5HTP-induced head twitches at 15 mg/kg, ip measured for 5 mins at every 5 mins interval for 1 hr relative to control",Other,24486417.0,
1097,1071697,1,1,,103307946,60795,Unspecified,,,,,"Antipsychotic activity in albino mouse assessed as inhibition of apomorphine-induced climbing behaviour at 15 mg/kg, ip measured after 10 mins at 5 mins interval for 30 mins relative to control",Other,24486417.0,
1098,1083227,1,2,,103307946,60795,Unspecified,,,,,"Induction of catalepsy in Mus musculus albino (mouse) at 25 mg/kg, ip measured after 20 min for 5 min",Other,,
1099,1083228,1,2,,103307946,60795,Unspecified,,,,,"Atypical antipsychotic activity in Mus musculus albino (mouse) assessed as inhibition of apomorphine-induced climbing behaviour at 25 mg/kg, ip administered 30 min prior to apomorphine-challenge measured after 5 min for 30 min relative to control",Other,,
1100,1083230,1,2,,103307946,60795,Unspecified,,,,,"Atypical antipsychotic activity in Mus musculus albino (mouse) assessed as inhibition of 5HTP-induced head twitching at 25 mg/kg, ip administered 30 min prior to apomorphine-challenge measured after 20 min for 5 min",Other,,
1101,1097336,1,3,,103307946,60795,Unspecified,,,,,Drug level in Homo sapiens (human) whole blood assessed as retention time by UPLC-TOF-MS analysis,Other,,
1102,1117298,1,2,,170465392,60795,Inactive,,,1.7783,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1103,1117301,1,2,,170465392,60795,Inactive,,,19.9526,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel",Confirmatory,,
1104,1117302,1,2,,170465392,60795,Inactive,,,44.6684,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel",Confirmatory,,
1105,1117303,1,2,,170465392,60795,Inactive,,,14.13,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel",Confirmatory,,
1106,1117304,1,2,,170465392,60795,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1107,1117305,1,2,,170465392,60795,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1108,1117310,1,1,,170465392,60795,Inactive,,,1.7782799999999999,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1109,1117311,1,1,,170465392,60795,Inactive,,,19.9526,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel",Confirmatory,,
1110,1117312,1,1,,170465392,60795,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1111,1117314,1,1,,170465392,60795,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1112,1117315,1,1,,170465392,60795,Inactive,,,44.6684,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel",Confirmatory,,
1113,1117318,1,1,,170465392,60795,Active,,,14.1254,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel",Confirmatory,,
1114,1117319,1,2,,26719891,60795,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1115,1117319,1,2,,26719891,60795,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1116,1117326,1,1,,170465392,60795,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1117,1117329,1,1,,170465392,60795,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1118,1117336,1,1,,170465392,60795,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1119,1117340,1,1,,170465392,60795,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1120,1117341,1,1,,170465392,60795,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1121,1117342,1,1,,170465392,60795,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1122,1117343,1,1,,170465392,60795,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1123,1117346,1,1,,170465392,60795,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1124,1119672,2,2,,103307946,60795,Active,231454.0,3350.0,0.01,Ki,Binding affinity to serotonin 5-HT1A receptor (unknown origin) by PDSP assay,Confirmatory,,
1125,1119673,2,2,,103307946,60795,Active,112821.0,3351.0,1.0,Ki,Binding affinity to serotonin 5-HT1B receptor (unknown origin) by PDSP assay,Confirmatory,,
1126,1119674,2,2,,103307946,60795,Active,112819.0,3352.0,0.1,Ki,Binding affinity to serotonin 5-HT1D receptor (unknown origin) by PDSP assay,Confirmatory,,
1127,1119675,2,2,,103307946,60795,Unspecified,112822.0,3354.0,1.0,Ki,Binding affinity to serotonin 5-HT1E receptor (unknown origin) by PDSP assay,Confirmatory,,
1128,1119676,2,2,,103307946,60795,Active,543727.0,3356.0,0.01,Ki,Binding affinity to serotonin 5-HT2A receptor (unknown origin) by PDSP assay,Confirmatory,,
1129,1119678,2,2,,103307946,60795,Active,112816.0,3358.0,1.0,Ki,Binding affinity to serotonin 5-HT2C receptor (unknown origin) by PDSP assay,Confirmatory,,
1130,1119679,2,2,,103307946,60795,Active,1168222.0,3359.0,1.0,Ki,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,Confirmatory,,
1131,1119681,2,2,,103307946,60795,Active,1345607.0,3361.0,1.0,Ki,Binding affinity to serotonin 5-HT5A receptor (unknown origin) by PDSP assay,Confirmatory,,
1132,1119682,2,2,,103307946,60795,Unspecified,1703010.0,3362.0,1.0,Ki,Binding affinity to serotonin 5-HT6 receptor (unknown origin) by PDSP assay,Confirmatory,,
1133,1119683,2,2,,103307946,60795,Active,8488960.0,3363.0,0.1,Ki,Binding affinity to serotonin 5-HT7 receptor (unknown origin) by PDSP assay,Confirmatory,,
1134,1119684,2,2,,103307946,60795,Active,118228.0,1812.0,1.0,Ki,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,Confirmatory,,
1135,1119685,2,2,,103307946,60795,Active,118206.0,1813.0,0.001,Ki,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,Confirmatory,,
1136,1119686,2,2,,103307946,60795,Active,1169206.0,1814.0,0.01,Ki,Binding affinity to dopamine D3 receptor (unknown origin) by PDSP assay,Confirmatory,,
1137,1119687,2,2,,103307946,60795,Active,1345939.0,1815.0,1.0,Ki,Binding affinity to dopamine D4 receptor (unknown origin) by PDSP assay,Confirmatory,,
1138,1119688,2,2,,103307946,60795,Unspecified,118214.0,1816.0,1.0,Ki,Binding affinity to dopamine D5 receptor (unknown origin) by PDSP assay,Confirmatory,,
1139,1119689,2,2,,103307946,60795,Active,1168246.0,148.0,0.1,Ki,Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay,Confirmatory,,
1140,1119690,2,2,,103307946,60795,Active,116241241.0,147.0,0.1,Ki,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,Confirmatory,,
1141,1119692,2,2,,103307946,60795,Active,1351829.0,150.0,0.1,Ki,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,Confirmatory,,
1142,1119693,2,2,,103307946,60795,Active,613504690.0,151.0,1.0,Ki,Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay,Confirmatory,,
1143,1119694,2,2,,103307946,60795,Active,20141211.0,152.0,0.1,Ki,Binding affinity to adrenergic alpha2C receptor (unknown origin) by PDSP assay,Confirmatory,,
1144,1119695,2,2,,103307946,60795,Active,547645.0,3269.0,0.1,Ki,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,Confirmatory,,
1145,1119697,2,2,,103307946,60795,Unspecified,113118.0,1128.0,1.0,Ki,Binding affinity to M1 receptor (unknown origin) by PDSP assay,Confirmatory,,
1146,1119698,2,2,,103307946,60795,Unspecified,113122.0,1129.0,1.0,Ki,Binding affinity to M2 receptor (unknown origin) by PDSP assay,Confirmatory,,
1147,1119699,2,2,,103307946,60795,Unspecified,113125.0,1131.0,1.0,Ki,Binding affinity to M3 receptor (unknown origin) by PDSP assay,Confirmatory,,
1148,1119700,2,2,,103307946,60795,Unspecified,23503039.0,1132.0,1.0,Ki,Binding affinity to M4 receptor (unknown origin) by PDSP assay,Confirmatory,,
1149,1119701,2,2,,103307946,60795,Unspecified,543761.0,1133.0,1.0,Ki,Binding affinity to M5 receptor (unknown origin) by PDSP assay,Confirmatory,,
1150,1152659,1,1,,103307946,60795,Inactive,,,,,Antipsychotic-like activity in po dosed Wistar rat assessed as inhibition of MK-801-induced hyperlocomotion administered 45 mins prior to MK-801 challenge measured 60 mins post-drug administration,Other,24805037.0,
1151,1152660,1,1,,103307946,60795,Inactive,,,,,Antipsychotic-like activity in po dosed Wistar rat assessed as inhibition of DOI-induced head twitches measured after 60 mins,Other,24805037.0,
1152,1152663,1,1,,103307946,60795,Unspecified,,,,,"Effect on cognition in Wistar rat assessed as memory disruption at 100 mg/kg, po administered 60 mins prior to training session measured during test session 24 hrs after training session by step-through passive avoidance test",Other,24805037.0,
1153,1153294,1,3,,103307946,60795,Active,118228.0,1812.0,0.31,Ki,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,Confirmatory,24831693.0,
1154,1153295,1,3,,103307946,60795,Active,118206.0,1813.0,0.00054,Ki,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,Confirmatory,24831693.0,
1155,1153296,1,3,,103307946,60795,Active,118206.0,1813.0,0.00045,Ki,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,Confirmatory,24831693.0,
1156,1153297,1,3,,103307946,60795,Active,1169206.0,1814.0,0.003,Ki,Displacement of [3H]Spiperone from human dopamine D3 receptor expressed in CHO cells by competitive binding assay,Confirmatory,24831693.0,
1157,1153298,1,1,,103307946,60795,Active,,,0.081,Ki,Displacement of [3H]Spiperone from human dopamine D4.4 receptor expressed in CHO cells by competitive binding assay,Confirmatory,24831693.0,
1158,1153299,1,2,,103307946,60795,Active,,,0.08800000000000001,Ki,Displacement of [3H]WAY-100635 from 5-HT1A receptor in pig cerebral cortex homogenates by competitive binding assay,Confirmatory,24831693.0,
1159,1153300,1,3,,103307946,60795,Active,543727.0,3356.0,0.004,Ki,Displacement of [3H]-ketanserin from human 5HT2A receptor expressed in HEK293 cells by competitive binding assay,Confirmatory,24831693.0,
1160,1153301,3,2,,103307946,60795,Active,,,0.017,Ki,Displacement of [3Hprazosin from adrenergic alpha1 receptor in pig cerebral cortex homogenates by competitive binding assay,Confirmatory,24831693.0,
1161,1153304,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphao1 after 30 mins by [35S]GTPgammaS binding assay relative to quinpirole,Other,24831693.0,
1162,1153305,4,1,,103307946,60795,Active,118206.0,1813.0,0.15849000000000002,EC50,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay,Confirmatory,24831693.0,
1163,1153306,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay relative to quinpirole,Other,24831693.0,
1164,1153307,4,1,,103307946,60795,Active,1169206.0,1814.0,0.0195,EC50,Agonist activity at human dopamine D3 receptor transiently expressed in HEK293 cells co-expressing Galphao1 after 30 mins by [35S]GTPgammaS binding assay,Confirmatory,24831693.0,
1165,1153308,1,3,,103307946,60795,Unspecified,1169206.0,1814.0,,,Agonist activity at human dopamine D3 receptor transiently expressed in HEK293 cells co-expressing Galphao1 after 30 mins by [35S]GTPgammaS binding assay relative to quinpirole,Other,24831693.0,
1166,1153309,3,2,,103307946,60795,Active,118206.0,1813.0,0.01122,IC50,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,Confirmatory,24831693.0,
1167,1153310,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay relative to qunipirole,Other,24831693.0,
1168,1157845,3,1,,103307946,60795,Unspecified,118206.0,1813.0,,EC50,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated for 30 mins by AlphaScreen assay,Confirmatory,24827597.0,
1169,1157846,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Intrinsic activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated for 30 mins by AlphaScreen assay relative to control,Other,24827597.0,
1170,1157847,2,2,,103307946,60795,Unspecified,118206.0,1813.0,,EC50,Agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,Confirmatory,24827597.0,
1171,1157848,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Ratio of intrinsic efficacy to KA for human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated for 30 mins by AlphaScreen assay,Other,24827597.0,
1172,1157849,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Intrinsic activity at human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,Other,24827597.0,
1173,1157850,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Ratio of intrinsic efficacy to KA for human D2L receptor expressed in FlpIn CHO cells assessed as induction of ERK1/2 phosphorylation by AlphaScreen assay,Other,24827597.0,
1174,1157851,1,3,,103307946,60795,Unspecified,118206.0,1813.0,,,Biased agonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of forskolin-stimulated cAMP production treated for 30 mins by AlphaScreen assay relative to dopamine,Other,24827597.0,
1175,1159390,1,2,,103307946,60795,Unspecified,,,,,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",Other,,
1176,1159509,1,1,,170465392,60795,Inconclusive,119626539.0,4790.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1177,1159515,1,1,,170465392,60795,Active,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1178,1159516,1,1,,170465392,60795,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1179,1159517,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1180,1159518,1,1,,170465392,60795,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1181,1159519,1,1,,170465392,60795,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1182,1159520,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1183,1159521,1,1,,170465392,60795,Inconclusive,15928672.0,19885.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1184,1159523,1,1,,170465392,60795,Active,15928672.0,19885.0,25.1151,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1185,1159524,1,1,,49666418,60795,Active,,,19.9526,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1186,1159525,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1187,1159526,1,1,,170465392,60795,Inconclusive,119627033.0,3725.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1188,1159527,1,1,,170465392,60795,Inconclusive,325495497.0,6256.0,0.6007,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1189,1159528,1,1,,170465392,60795,Inconclusive,119627033.0,3725.0,8.48517,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1190,1159529,1,1,,170465392,60795,Active,,,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1191,1159531,1,1,,170465392,60795,Inconclusive,325495497.0,6256.0,1.11001,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1192,1159551,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1193,1159552,1,1,,170465392,60795,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1194,1159553,2,1,,170465392,60795,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1195,1159555,1,1,,170465392,60795,Inconclusive,325495463.0,5914.0,26.6032,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1196,1159580,2,1,,268735198,60795,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1197,1159583,2,1,,178126986,60795,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
1198,1159606,1,1,,49666418,60795,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1199,1159607,2,1,,312310054,60795,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1200,1159614,1,2,,170465392,60795,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1201,1159620,1,1,,103307946,60795,Active,,,,,Summary of drug indications.,Other,,
1202,1169860,1,2,,103307946,60795,Active,118206.0,1813.0,0.0008,Ki,Binding affinity to dopamine D2 receptor (unknown origin),Confirmatory,25343529.0,
1203,1169861,1,2,,103307946,60795,Active,1169206.0,1814.0,0.0033,Ki,Binding affinity to dopamine D3 receptor (unknown origin),Confirmatory,25343529.0,
1204,1169862,1,2,,103307946,60795,Active,231454.0,3350.0,0.0056,Ki,Binding affinity to 5HT1A receptor (unknown origin),Confirmatory,25343529.0,
1205,1169863,1,2,,103307946,60795,Active,543727.0,3356.0,0.0087,Ki,Binding affinity to 5HT2A receptor (unknown origin),Confirmatory,25343529.0,
1206,1169864,1,2,,103307946,60795,Active,112816.0,3358.0,0.022000000000000002,Ki,Binding affinity to 5HT2C receptor (unknown origin),Confirmatory,25343529.0,
1207,1169865,1,1,,103307946,60795,Unspecified,,,,,Effect on spontaneous exploratory locomotor activity in sc dosed NMRI mouse measured for 30 mins with activity counts each 5 mins,Other,25343529.0,
1208,1169867,1,1,,103307946,60795,Inconclusive,,,,,Antipsychotic-like activity in sc dosed NMRI mouse assessed as reduction in MK801-induced locomotor activity dosed 15 to 30 mins before administration of MK801 measured for 60 mins,Other,25343529.0,
1209,1169869,1,1,,103307946,60795,Unspecified,,,,,Antipsychotic-like activity in sc dosed NMRI mouse assessed as reduction in methamphetamine-induced locomotor activity dosed 15 to 30 mins before administration of methamphetamine measured for 60 mins,Other,25343529.0,
1210,1169871,1,1,,103307946,60795,Unspecified,,,,,Antipsychotic-like activity in sc dosed NMRI mouse assessed as reduction in PCP-induced locomotor activity dosed 15 to 30 mins before administration of methamphetamine measured for 60 mins,Other,25343529.0,
1211,1196348,1,1,,103307946,60795,Unspecified,,,,,Anti-depressant-like activity in intraperitoneally dosed 3-months old Wistar rat assessed as reduction in saccharin self-administration,Other,25557493.0,
1212,1196349,1,1,,103307946,60795,Unspecified,,,,,Anti-depressant-like activity in intraperitoneally dosed 3-months old Wistar rat by Porsolt's forced swim test,Other,25557493.0,
1213,1196350,1,1,,103307946,60795,Inconclusive,,,,,Anti-depressant-like activity in intraperitoneally dosed >18-months old Wistar rat by Porsolt's forced swim test,Other,25557493.0,
1214,1196351,1,1,,103307946,60795,Unspecified,,,,,Anxiolytic activity in intraperitoneally dosed 3-months old Wistar rat by Vogel's conflict drinking test,Other,25557493.0,
1215,1196352,1,1,,103307946,60795,Inconclusive,,,,,Anxiolytic activity in intraperitoneally dosed 3-months old Wistar rat by open-field test,Other,25557493.0,
1216,1196353,1,1,,103307946,60795,Inconclusive,,,,,Anxiolytic activity in intraperitoneally dosed >18-months old Wistar rat by open-field test,Other,25557493.0,
1217,1196354,1,1,,103307946,60795,Inconclusive,,,,,Procognitive effect in intraperitoneally dosed 3-months old Wistar rat assessed as extinction of non-reinforced responding for sweet reward,Other,25557493.0,
1218,1196355,1,1,,103307946,60795,Unspecified,,,,,Effect on pain threshold in intraperitoneally dosed Wistar rat by hot plate test,Other,25557493.0,
1219,1196356,1,1,,103307946,60795,Unspecified,,,,,Effect on water consumption in intraperitoneally dosed Wistar rat by free drinking test,Other,25557493.0,
1220,1210167,1,1,,103307946,60795,Unspecified,,,,,Unbound brain to plasma partition coefficient of the compound in mdr1a-deficient mouse at 3 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1221,1210172,1,1,,103307946,60795,Unspecified,,,,,Unbound brain to plasma partition coefficient of the compound in wild type Sprague-Dawley rat expressing Abcb1a at 6 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1222,1210177,1,1,,103307946,60795,Unspecified,,,,,Unbound brain to plasma partition coefficient of the compound in mdr1a-deficient rat at 6 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1223,1210178,1,1,,103307946,60795,Unspecified,,,,,Fraction unbound in Crl:NMRI(Han) mouse brain at 1 uM after 5 hrs by equilibrium dialysis method,Other,,
1224,1210184,1,1,,103307946,60795,Unspecified,,,,,Unbound brain to plasma partition coefficient of the compound in wild type Crl:CF1 mouse expressing Abcb1a mutant at 3 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1225,1210194,1,2,,103307946,60795,Unspecified,,,,,Total plasma concentration in wild type Crl:CF1 mouse expressing Abcb1a mutant at 3 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1226,1210195,1,1,,103307946,60795,Unspecified,,,,,Total drug level in wild type Crl:CF1 mouse brain expressing Abcb1a mutant at 3 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1227,1210196,1,1,,103307946,60795,Unspecified,,,,,Total brain to plasma partition coefficient of the compound in wild type Crl:CF1 mouse expressing Abcb1a mutant at 3 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1228,1210212,1,2,,103307946,60795,Unspecified,,,,,Total plasma concentration in mouse at 3 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1229,1210213,1,1,,103307946,60795,Unspecified,,,,,Total drug level in mdr1a-deficient mouse brain at 3 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1230,1210214,1,1,,103307946,60795,Unspecified,,,,,Total brain to plasma partition coefficient of the compound in mdr1a-deficient mouse at 3 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1231,1210215,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Sprague-Dawley rat plasma at 1 uM after 5 hrs by equilibrium dialysis method,Other,22112383.0,
1232,1210216,1,1,,103307946,60795,Unspecified,,,,,Fraction unbound in Sprague-Dawley rat brain at 1 uM after 5 hrs by equilibrium dialysis method,Other,22112383.0,
1233,1210218,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Crl:NMRI(Han) mouse plasma at 1 uM after 5 hrs by equilibrium dialysis method,Other,22112383.0,
1234,1210231,1,2,,103307946,60795,Unspecified,,,,,Total plasma concentration in wild type Sprague-Dawley rat expressing Abcb1a at 6 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1235,1210232,1,1,,103307946,60795,Unspecified,,,,,Total drug level in wild type Sprague-Dawley rat brain expressing Abcb1a at 6 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1236,1210233,1,1,,103307946,60795,Unspecified,,,,,Total brain to plasma partition coefficient of the compound in wild type Sprague-Dawley rat expressing Abcb1a at 6 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1237,1210246,1,2,,103307946,60795,Unspecified,,,,,Total plasma concentration in mdr1a-deficient Sprague-Dawley rat at 6 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1238,1210247,1,1,,103307946,60795,Unspecified,,,,,Total drug level in mdr1a-deficient rat brain at 6 mg/kg/day administered through continuous minipump treatment for 3 days by UPLC-MS analysis,Other,22112383.0,
1239,1210248,1,1,,103307946,60795,Unspecified,,,,,Total brain to plasma partition coefficient of the compound in mdr1a-deficient rat at 6 mg/kg/day administered through continuous minipump treatment for 3 days,Other,22112383.0,
1240,1220554,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Wistar Han rat brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1241,1220555,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Sprague-Dawley rat brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1242,1220556,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in CD-1 mouse brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1243,1220557,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Hartley guinea pig brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1244,1220558,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in Beagle dog brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1245,1220559,1,2,,103307946,60795,Unspecified,,,,,Fraction unbound in cynomolgus monkey brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1246,1220560,1,1,,103307946,60795,Unspecified,,,,,Fraction unbound in human occipital cortex at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
1247,1224824,1,1,,174006897,60795,Inactive,,,33.1734,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
1248,1224825,1,1,,174006897,60795,Inactive,,,0.0662,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
1249,1224834,3,1,,170465392,60795,Active,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1250,1224835,1,1,,170465392,60795,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1251,1224836,1,1,,170465392,60795,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1252,1224837,1,1,,170465392,60795,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1253,1224838,1,1,,170465392,60795,Inactive,66775687.0,9970.0,18.8336,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1254,1224839,1,1,,170465392,60795,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1255,1224840,3,1,,170465392,60795,Inconclusive,,,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1256,1224841,3,1,,170465392,60795,Active,325495545.0,2101.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1257,1224842,3,1,,170465392,60795,Inactive,325495545.0,2101.0,14.9601,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1258,1224843,1,1,,170465392,60795,Inconclusive,119601739.0,7253.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1259,1224844,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1260,1224845,1,1,,170465392,60795,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1261,1224846,1,1,,170465392,60795,Inconclusive,11995455.0,3091.0,30.1065,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1262,1224847,1,1,,170465392,60795,Active,,,55.1965,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1263,1224848,3,1,,170465392,60795,Active,325495545.0,2101.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1264,1224849,3,1,,170465392,60795,Inactive,325495545.0,2101.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1265,1224857,2,1,,170465392,60795,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1266,1224857,2,1,,174006897,60795,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1267,1224859,2,1,,170465392,60795,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1268,1224859,2,1,,174006897,60795,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1269,1224863,1,1,,176484073,60795,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1270,1224863,1,1,,316919494,60795,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1271,1224865,1,2,,49666418,60795,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1272,1224867,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1273,1224868,1,1,,170465392,60795,Active,,,10.6822,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1274,1224869,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1275,1224870,1,1,,170465392,60795,Inconclusive,,,30.1065,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1276,1224871,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1277,1224872,1,1,,170465392,60795,Active,,,10.6822,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1278,1224873,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1279,1224874,1,1,,170465392,60795,Active,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1280,1224875,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1281,1224876,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1282,1224877,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1283,1224878,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1284,1224879,1,1,,170465392,60795,Active,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1285,1224880,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1286,1224881,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1287,1224882,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1288,1224883,1,1,,170465392,60795,Active,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1289,1224884,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1290,1224885,1,1,,170465392,60795,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1291,1224886,1,1,,170465392,60795,Active,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1292,1224887,1,1,,170465392,60795,Active,,,21.3138,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1293,1224888,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1294,1224889,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1295,1224890,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1296,1224892,1,1,,170465392,60795,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1297,1224893,1,1,,170465392,60795,Inconclusive,66775687.0,9970.0,11.8832,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1298,1224894,1,1,,170465392,60795,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1299,1224895,1,1,,170465392,60795,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1300,1224896,1,1,,170465392,60795,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1301,1224905,2,1,,92308936,60795,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1302,1224905,2,1,,92308936,60795,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1303,1232327,1,1,,103307946,60795,Active,118206.0,1813.0,0.000343,Ki,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,Confirmatory,25826710.0,
1304,1232328,1,1,,103307946,60795,Active,1169206.0,1814.0,0.001,Ki,Displacement of [3H]N-methylspiperone from human dopamine D3 receptor expressed in HEK293 cells,Confirmatory,25826710.0,
1305,1232329,1,1,,103307946,60795,Active,1345939.0,1815.0,0.0571,Ki,Displacement of [3H]N-methylspiperone from human dopamine D4 receptor expressed in HEK293 cells,Confirmatory,25826710.0,
1306,1232330,1,1,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for human dopamine D2 receptor to KI for human dopamine D3 receptor",Other,25826710.0,
1307,1232331,1,1,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for human dopamine D4 receptor to KI for human dopamine D3 receptor",Other,25826710.0,
1308,1233019,1,1,,103307946,60795,Unspecified,,,,,Antipsychotic activity in ip dosed CD-1 mouse assessed as inhibition of D-amphetamine-induced hyperlocomotor activity,Other,25936259.0,
1309,1233020,1,1,,103307946,60795,Unspecified,,,,,Toxicity in ip dosed spontaneous locomotor activity CD-1 mouse model assessed as dose required to cause sedation,Other,25936259.0,
1310,1233023,1,1,,103307946,60795,Inactive,,,,,"Anti-depressant like activity in Swiss albino mouse assessed as shortening of immobility time at 0.01 to 0.1 mg/kg, ip by forced swim test",Other,25936259.0,
1311,1233026,1,1,,103307946,60795,Inactive,,,,,"Antianxiety-like activity in Swiss albino mouse assessed as number of punished crossings at 0.06 to 0.5 mg/kg, ip by four-plate test",Other,25936259.0,
1312,1233027,1,1,,103307946,60795,Unspecified,,,,,Toxicity in ip dosed CD-1 mouse assessed as minimum dose required for induction of catalepsy by bar test,Other,25936259.0,
1313,1233028,1,1,,103307946,60795,Unspecified,,,,,Ratio of MED for catalepsy in CD-1 mouse to ED50 for antipsychotic activity in CD-1 mouse,Other,25936259.0,
1314,1242908,1,1,,103307946,60795,Active,543727.0,3356.0,0.0087,Ki,Binding affinity to 5-HT2A receptor (unknown origin),Confirmatory,26227779.0,
1315,1245087,1,1,,103307946,60795,Unspecified,,,,,"Selectivity index, ratio of Ki for human 5HT2A receptor to Ki for human dopamine D2 receptor",Other,26299826.0,
1316,1245089,1,1,,103307946,60795,Active,118206.0,1813.0,0.00047999999999999996,Ki,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,Confirmatory,26299826.0,
1317,1245094,1,1,,103307946,60795,Active,543727.0,3356.0,0.004,Ki,Displacement of [3H]ketanserin from human 5-HT2A receptor expressed in HEK293 cell membranes by radioligand competition binding assay,Confirmatory,26299826.0,
1318,1245096,1,1,,103307946,60795,Active,118206.0,1813.0,0.0389,EC50,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphao1 by [35S]GTPgammaS binding assay,Confirmatory,26299826.0,
1319,1245097,1,1,,103307946,60795,Unspecified,118206.0,1813.0,,,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphao1 by [35S]GTPgammaS binding assay relative to quinpirole,Other,26299826.0,
1320,1245098,1,1,,103307946,60795,Active,118206.0,1813.0,0.15849000000000002,EC50,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphai2 by [35S]GTPgammaS binding assay,Confirmatory,26299826.0,
1321,1245099,1,1,,103307946,60795,Unspecified,118206.0,1813.0,,,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphai2 by [35S]GTPgammaS binding assay relative to quinpirole,Other,26299826.0,
1322,1245100,1,1,,103307946,60795,Inactive,118206.0,1813.0,,EC50,Activity at pro-link-tagged D2S-ARMS2PK2 (unknown origin) expressed in HEK293 cells by beta-arrestin-2 recruitment assay,Confirmatory,26299826.0,
1323,1257655,1,1,,103307946,60795,Active,543727.0,3356.0,0.009000000000000001,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, aA1, 5-HT2C and H1 Receptors.",Confirmatory,,
1324,1257656,1,1,,103307946,60795,Active,400630.0,6532.0,0.24,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, alpha;A1, 5-HT2C and H1 Receptors.",Confirmatory,,
1325,1257657,1,1,,103307946,60795,Active,112816.0,3358.0,0.13,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, alpha;A1, 5-HT2C and H1 Receptors.",Confirmatory,,
1326,1257658,1,1,,103307946,60795,Active,,,0.027999999999999997,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, alpha;A1, 5-HT2C and H1 Receptors.",Confirmatory,,
1327,1257659,1,1,,103307946,60795,Active,118206.0,1813.0,0.0016,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, alpha;A1, 5-HT2C and H1 Receptors.",Confirmatory,,
1328,1257660,1,1,,103307946,60795,Active,1168246.0,148.0,0.026000000000000002,Ki,"BindingDB_Patents: Binding Assay. Binding assay using 5-HT2A, Dopamine D2, SERT, alpha;A1, 5-HT2C and H1 Receptors.",Confirmatory,,
1329,1258724,1,1,,103307946,60795,Active,112812.0,24473.0,0.00335,IC50,"BindingDB_Patents: Receptor Binding Assay. Isotope ligand 3H-8-OH-DPAT (67.0 Ci/mmol) was purchased from PerkinElmer Company; 5-HT was purchased from RBI Company; GF/C glass fiber filter paper was purchased from Whatman Company; Tris was imported and divided into aliquots; PPO, POPOP were purchased from Shanghai No. 1 Reagent Factory; lipid-soluble scintillation solution. Beckman LS-6500 Multi-function Liquid Scintillation Counter was used.Procedures(1) The prepared membrane was first applied with appropriate amount of buffer (0.05 M Tris-HCl buffer, containing 0.1% ascorbic acid, 10 um pargyline and 4 mM CaCl2), and homogenizer was used for evenly dispersing. 15 tubes were mixed into a 100 ml container, and appropriate amount of homogenized liquid was added to give 50 ml of membrane suspension, which was reserved for future use.(2) 100 uL of membrane preparation and 100 uL of buffer (0.05 M Tris-HCl buffer, containing 0.1% ascorbic acid, 10 um pargyline and 4 mM CaCl2) were added into",Confirmatory,,
1330,1258725,1,1,,103307946,60795,Active,112808.0,29595.0,0.01151,IC50,"BindingDB_Patents: Receptor Binding Assay. Materials for the Receptor Binding AssayIsotope ligand [3H]-Ketanserin (67.0 Ci/mmol) was purchased from PerkinElmer Company; Methysergide was purchased from RBI Company; GF/C glass fiber filter paper was purchased from Whatman Company; Tris was imported and divided into aliquots; PPO, POPOP were purchased from Shanghai No. 1 Reagent Factory; lipid-soluble scintillation solution. Beckman LS-6500 Multi-function Liquid Scintillation Counter was used.Procedures(1) The prepared membrane was first applied with appropriate amount of buffer (0.05 M Tris-HCl buffer: 6.05 g of Tris was dissolved in 1000 ml of double-distilled water, and concentrated HCl was used to adjust to pH 7.5), and homogenizer was used for evenly dispersing. 15 tubes were mixed into a 100 ml container, and appropriate amount of homogenized liquid was added to give 50 ml of membrane suspension, which was reserved for future use.(2) 100 uL of membrane preparation and 100 uL of buff",Confirmatory,,
1331,1258812,1,1,,103307946,60795,Active,,,0.0257,IC50,"BindingDB_Patents: Receptor Binding Assay. (1) The prepared membrane was first applied with appropriate amount of homogenized liquid, and homogenizer was used for evenly dispersing. 15 tubes were mixed into a 100 ml container, and appropriate amount of homogenized liquid was added to give 50 ml of membrane suspension, which was reserved for future use.(2) 100 uL of membrane preparation and 100 uL of buffer were added into each reaction tube.(3) 100 uL of homogenized liquid was added into the total binding tube (TB), 100 uL of mianserin (final concentration 10-5 M) was added into the non-specific binding tube (NB), and 100 uL of the test compound (final concentration 10-5 M) was added into the specific binding tube (SB) for each compound.(4) 10 uL of radioactive ligand [3H]-mesulergine was respectively added into each reaction tube (2 parallel tubes were used for each reaction tube, and each of them was placed on ice when adding sample).(5) Each of the reaction tubes was incubated at 37",Confirmatory,,
1332,1258813,1,1,,103307946,60795,Active,,,0.0379,IC50,"BindingDB_Patents: Receptor Assay. Competitive binding test for receptors: 20 microl of each of the test compounds and 20 microl of the radioactive ligand together with 160 microl of the receptor proteins were added into the reaction tubes, and the final concentrations of the test compound and the positive drug were all 10 micromol/L. After 50 min of incubation in 30 degrees  C. water bath, the tubes were immediately moved to ice bath to terminate the reactions. GF/C glass fiber filter papers were used for rapid sucking filtration on a Millipore cell sample collector, elution buffer (50 mM Tris-HCl, PH 7.4) was applied for 3 mlx3 times, and microwave was applied for 4-5 min for drying. The filter papers were moved into 0.5 ml centrifuge tubes, and 500 microl of lipid-soluble scintillation solution was added. The tubes were allowed to stand still for over 30 min in dark, and the intensities of radioactivity were measured by a counter.",Confirmatory,,
1333,1259241,1,1,,170465392,60795,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1334,1259242,1,1,,170465392,60795,Active,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1335,1259243,1,1,,170465392,60795,Active,124375976.0,367.0,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1336,1259244,1,1,,170465392,60795,Active,348019627.0,2099.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1337,1259247,1,1,,170465392,60795,Inconclusive,124375976.0,367.0,11.0053,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1338,1259248,1,1,,170465392,60795,Inconclusive,348019627.0,2099.0,19.5704,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1339,1259251,1,1,,46386763,60795,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of Unc-51 Like Autophagy Activating Kinase 1 (ULK1).,Screening,,
1340,1259252,1,1,,174006897,60795,Inconclusive,169655958.0,,2.3485,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
1341,1259253,1,1,,174006897,60795,Inconclusive,169655958.0,,0.0013,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
1342,1259255,1,1,,174006897,60795,Inconclusive,169655958.0,,26.3506,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
1343,1259256,1,1,,174006897,60795,Inconclusive,169655958.0,,23.485,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
1344,1259309,1,1,,178126986,60795,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1345,1259310,1,1,,46386763,60795,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1346,1259310,1,1,,333473074,60795,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1347,1259310,1,1,,333473290,60795,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1348,1259311,1,1,,178126986,60795,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1349,1259313,1,1,,49666418,60795,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1350,1259318,1,1,,49666283,60795,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1351,1259325,1,2,,336954574,60795,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
1352,1259344,1,1,,144205281,60795,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1353,1259355,1,1,,144205281,60795,Inconclusive,,,39.8107,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1354,1259356,1,1,,144205281,60795,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1355,1259364,1,1,,170465392,60795,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1356,1259365,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1357,1259366,1,1,,170465392,60795,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1358,1259367,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1359,1259368,1,1,,170465392,60795,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1360,1259369,1,1,,170465392,60795,Active,109731339.0,2737.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1361,1259377,1,1,,170465392,60795,Inconclusive,54288833.0,2100.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1362,1259378,1,1,,170465392,60795,Inconclusive,54288833.0,2100.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1363,1259379,1,1,,170465392,60795,Active,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1364,1259380,1,1,,170465392,60795,Active,,,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1365,1259381,1,1,,170465392,60795,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1366,1259382,1,1,,170465392,60795,Active,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1367,1259383,1,1,,170465392,60795,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1368,1259384,1,1,,170465392,60795,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1369,1259385,1,1,,170465392,60795,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1370,1259386,1,1,,170465392,60795,Active,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1371,1259387,1,1,,170465392,60795,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1372,1259388,1,1,,170465392,60795,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1373,1259389,1,1,,124658892,60795,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1374,1259390,1,1,,170465392,60795,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1375,1259391,1,1,,170465392,60795,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1376,1259392,1,1,,170465392,60795,Active,109731339.0,2737.0,9.43918,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1377,1259393,1,1,,170465392,60795,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1378,1259394,1,1,,170465392,60795,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1379,1259395,1,1,,170465392,60795,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1380,1259396,1,1,,170465392,60795,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1381,1259400,1,1,,170465392,60795,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1382,1259401,1,1,,170465392,60795,Inconclusive,325495545.0,2101.0,9.80846,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1383,1259402,1,1,,170465392,60795,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1384,1259403,1,1,,170465392,60795,Inconclusive,325495545.0,2101.0,10.5909,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1385,1259404,1,1,,170465392,60795,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1386,1259406,1,1,,363920046,60795,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
1387,1259406,1,1,1.0,363920046,60795,Inactive,26638650.0,3778.0,0.0772334,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
1388,1259406,1,1,2.0,363920046,60795,Inactive,4758626.0,3779.0,0.0376774,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1389,1259406,1,1,3.0,363920046,60795,Inactive,5031823.0,10242.0,-0.00575766,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
1390,1259406,1,1,4.0,363920046,60795,Inactive,26051275.0,27345.0,0.0383022,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
1391,1259406,1,1,5.0,363920046,60795,Inactive,160410009.0,389816.0,-0.018541099999999998,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1392,1259406,1,1,6.0,363920046,60795,Inactive,26638650.0,3778.0,-0.0555173,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
1393,1259406,1,1,7.0,363920046,60795,Inactive,4758626.0,3779.0,0.0559972,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1394,1259406,1,1,8.0,363920046,60795,Inactive,5031823.0,10242.0,0.018130200000000003,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
1395,1259406,1,1,9.0,363920046,60795,Inactive,26051275.0,27345.0,0.0353457,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
1396,1259406,1,1,10.0,363920046,60795,Inactive,5031823.0,10242.0,0.037283,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
1397,1259413,1,2,,46386763,60795,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
1398,1259415,1,1,,49666283,60795,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1399,1259416,1,2,,340081460,60795,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1400,1259416,1,2,,375178164,60795,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1401,1259419,1,1,,135649956,60795,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,12629531.0,
1402,1259419,1,1,,135649956,60795,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,12784105.0,
1403,1259421,1,1,,340081460,60795,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1404,1259421,1,1,,375178164,60795,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1405,1259423,1,2,,354916240,60795,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
